Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Bacterial Infections and Mycoses

  Free Subscription


Articles published in Antimicrob Agents Chemother

Retrieve available abstracts of 390 articles:
HTML format
Text format



Single Articles


    August 2019
  1. WILLEMS HME, Stultz JS, Coltrane ME, Fortwendel JP, et al
    Disparate Candida albicans biofilm formation in clinical lipid emulsions due to capric acid mediated inhibition.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.01394.
    PubMed     Text format     Abstract available


  2. WANG Q, Modongo C, Allender C, Engelthaler DM, et al
    Utility of targeted, amplicon-based deep sequencing to detect resistance to first-line tuberculosis drugs in Botswana.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.00982.
    PubMed     Text format     Abstract available


  3. NAKAMURA I, Ohsumi K, Takeda S, Katsumata K, et al
    ASP2397, a novel natural compound that exhibits rapid and potent fungicidal activity against Aspergillus species through a specific transporter.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.02689.
    PubMed     Text format     Abstract available


  4. WIEDERHOLD NP, Najvar LK, Jaramillo R, Olivo M, et al
    Extended-Interval Dosing of Rezafungin against Azole-Resistant Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.01165.
    PubMed     Text format     Abstract available


  5. PARK Y, Ahn YM, Jonnala S, Oh S, et al
    Inhibition of CorA dependent Magnesium Homeostasis is cidal in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.01006.
    PubMed     Text format     Abstract available


  6. TUCKER EW, Pieterse L, Zimmerman MD, Udwadia ZF, et al
    Delamanid Central Nervous System Pharmacokinetics in Tuberculous Meningitis in Rabbits and Humans.
    Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.00913.
    PubMed     Text format     Abstract available


  7. NISHIMOTO AT, Whaley SG, Wiederhold NP, Zhang Q, et al
    Impact of the major Candida glabrata triazole resistance determinants on the activity of the novel investigational tetrazoles VT-1598 and VT-1161.
    Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.01304.
    PubMed     Text format     Abstract available


  8. WRIGHT WF, Bejou N, Shields RK, Marr K, et al
    Amphotericin B Induction with Voriconazole Consolidation as Salvage Therapy for FKS-Associated Echinocandin Resistance in Candida glabrata Septic Arthritis and Osteomyelitis.
    Antimicrob Agents Chemother. 2019;63.
    PubMed     Text format     Abstract available


    July 2019
  9. KARAU MJ, Schmidt-Malan SM, Yan Q, Greenwood-Quaintance KE, et al
    Exebacase in Addition to Daptomycin is More Active than Daptomycin or Exebacase Alone in Methicillin-Resistant Staphylococcus aureus Osteomyelitis in Rats.
    Antimicrob Agents Chemother. 2019 Jul 29. pii: AAC.01235.
    PubMed     Text format     Abstract available


  10. LI H, Salinger DH, Everitt D, Li M, et al
    Long-Term Effects on QT prolongation of Pretomanid, Alone and in Combinations, in Patients with Tuberculosis.
    Antimicrob Agents Chemother. 2019 Jul 29. pii: AAC.00445.
    PubMed     Text format     Abstract available


  11. SARATHY JP, Ragunathan P, Shin J, Cooper CB, et al
    TBAJ-876 retains Bedaquiline's activity against subunit c and of Mycobacterium tuberculosis F-ATP synthase.
    Antimicrob Agents Chemother. 2019 Jul 29. pii: AAC.01191.
    PubMed     Text format     Abstract available


  12. GONCALVES BV, Portela R, Lobo R, Figueiredo TA, et al
    The role of MurT C-terminal domain in the amidation of Staphylococcus aureus peptidoglycan.
    Antimicrob Agents Chemother. 2019 Jul 29. pii: AAC.00957.
    PubMed     Text format     Abstract available


  13. PRATER AG, Mehta HH, Kosgei AJ, Miller WR, et al
    Environment Shapes the Accessible Daptomycin Resistance Mechanisms in Enterococcus faecium.
    Antimicrob Agents Chemother. 2019 Jul 22. pii: AAC.00790.
    PubMed     Text format     Abstract available


  14. WATSON A, Oh JT, Sauve K, Bradford PA, et al
    Antimicrobial Activity of Exebacase (Lysin CF-301) Against the Most Common Causes of Infective Endocarditis.
    Antimicrob Agents Chemother. 2019 Jul 22. pii: AAC.01078.
    PubMed     Text format     Abstract available


  15. KORYCKA-MACHALA M, Viljoen A, Pawelczyk J, Borowka P, et al
    1H-benzo[d]imidazole derivatives affect MmpL3 in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jul 22. pii: AAC.00441.
    PubMed     Text format     Abstract available


  16. G C B, Sahukhal GS, Elasri MO
    Role of the msaABCR operon in cell wall biosynthesis, autolysis, integrity, and antibiotic resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Jul 15. pii: AAC.00680.
    PubMed     Text format     Abstract available


  17. BELLOUARD R, Deschanvres C, Deslandes G, Dailly E, et al
    Cefazolin dosage adaptation in bacteremia and infective endocarditis based on a nomogram: a population pharmacokinetic study.
    Antimicrob Agents Chemother. 2019 Jul 15. pii: AAC.00806.
    PubMed     Text format     Abstract available


  18. YOUSFI H, Cassagne C, Ranque S, Rolain JM, et al
    Repurposing of ribavirin as an adjunct therapy against invasive Candida strains: In vitro study.
    Antimicrob Agents Chemother. 2019 Jul 15. pii: AAC.00263.
    PubMed     Text format     Abstract available


  19. RIVERO-MENENDEZ O, Soto-Debran JC, Medina N, Lucio J, et al
    Molecular identification, antifungal susceptibility testing and mechanisms of azole resistance in Aspergillus spp. received within a surveillance program on antifungal resistance in Spain.
    Antimicrob Agents Chemother. 2019 Jul 8. pii: AAC.00865.
    PubMed     Text format     Abstract available


  20. VATANSHENASSAN M, Arastehfar A, Boekhout T, Berman J, et al
    Rapid antifungal susceptibility testing of Candida glabrata isolates against anidulafungin from positive blood culture by MBT ASTRA.
    Antimicrob Agents Chemother. 2019 Jul 8. pii: AAC.00554.
    PubMed     Text format     Abstract available


  21. KIDWAI S, Bouzeyen R, Chakraborti S, Khare N, et al
    NU-6027 inhibits growth of Mycobacterium tuberculosis by targeting Protein Kinase D and Protein Kinase G.
    Antimicrob Agents Chemother. 2019 Jul 8. pii: AAC.00996.
    PubMed     Text format     Abstract available


  22. DAHESH S, Wong B, Nizet V, Sakoulas G, et al
    Treatment of Multidrug-Resistant Vancomycin-Resistant Enterococcus faecium Hardware-Associated Vertebral Osteomyelitis with Oritavancin plus Ampicillin.
    Antimicrob Agents Chemother. 2019;63.
    PubMed     Text format     Abstract available


  23. GHODOUSI A, Rizvi AH, Baloch AQ, Ghafoor A, et al
    Acquisition of cross-resistance to Bedaquiline and Clofazimine following treatment for Tuberculosis in Pakistan.
    Antimicrob Agents Chemother. 2019 Jul 1. pii: AAC.00915.
    PubMed     Text format     Abstract available


  24. LI Q, Cheng J, Wu Y, Wang Z, et al
    Effects of Delayed Antibiotic Therapy on Outcomes in Children with Streptococcus pneumoniae Sepsis.
    Antimicrob Agents Chemother. 2019 Jul 1. pii: AAC.00623.
    PubMed     Text format     Abstract available


    June 2019
  25. GREGOIRE M, Dailly E, Turnier PL, Garot D, et al
    High-dose ceftriaxone for bacterial meningitis: optimization of administration scheme based on nomogram.
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00634.
    PubMed     Text format     Abstract available


  26. YAMASHITA Y, Nagaoka K, Kimura H, Suzuki M, et al
    Efficacy of azithromycin in a mouse pneumonia model against hospital-acquired methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00149.
    PubMed     Text format     Abstract available


  27. NAKANO S, Fujisawa T, Ito Y, Chang B, et al
    Penicillin-binding protein typing, antibiotic resistance gene identification and molecular phylogenetic analysis of meropenem-resistant Streptococcus pneumoniae serotype 19A-CC3111 strains in Japan.
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00711.
    PubMed     Text format     Abstract available


  28. SEWELL TR, Zhang Y, Brackin AP, Shelton JMG, et al
    Elevated prevalence of azole resistant Aspergillus fumigatus in urban versus rural environments in the United Kingdom.
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00548.
    PubMed     Text format     Abstract available


  29. REHBERG N, Omeje E, Ebada SS, van Geelen L, et al
    3-O-Methyl-alkylgallates inhibit fatty acid desaturation in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.00136.
    PubMed     Text format     Abstract available


  30. RODRIGUEZ LOPEZ AL, Lee MR, Wang NB, Dunn KK, et al
    Small-molecule morphogenesis modulators enhance the ability of 14-helical beta-peptides to prevent Candida albicans biofilm formation.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.02653.
    PubMed     Text format     Abstract available


  31. LI D, Li XY, Schwarz S, Yang M, et al
    Tn6674, a Novel Enterococcal optrA-Carrying Multiresistance Transposon of the Tn554 Family.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.00809.
    PubMed     Text format     Abstract available


  32. LEE H, Boyle-Vavra S, Ren J, Jarusiewicz J, et al
    Identification of small molecules exhibiting oxacillin synergy through a novel assay for inhibition of vraTSR expression in methicillin resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.02593.
    PubMed     Text format     Abstract available


  33. BHAGWAT SS, Periasamy H, Takalkar SS, Chavan R, et al
    In vivo pharmacokinetic/pharmacodynamic targets of levonadifloxacin against Staphylococcus aureus in a neutropenic murine lung infection model.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.00909.
    PubMed     Text format     Abstract available


  34. PERICAS JM, Nathavitharana R, Garcia-de-la-Maria C, Falces C, et al
    Endocarditis Caused by Highly Penicillin-Resistant Viridans Group Streptococci: Still Room for Vancomycin-Based Regimens.
    Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.00516.
    PubMed     Text format     Abstract available


  35. OKUSANYA OO, Forrest A, Bhavnani SM, Fernandes P, et al
    Pharmacokinetic/Pharmacodynamic Evaluation of Solithromycin Against Streptococcus pneumoniae Using Data from a Neutropenic Murine-Lung Infection Model.
    Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.02606.
    PubMed     Text format     Abstract available


  36. TENERO D, Derimanov G, Carlton A, Tonkyn J, et al
    First time in human (FTIH) study and prediction of early bactericidal activity for GSK3036656, a potent Leucyl - tRNA synthetase inhibitor for tuberculosis treatment.
    Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.00240.
    PubMed     Text format     Abstract available


  37. MCNEIL MB, Cook GM
    Utilization of CRISPR interference to validate MmpL3 as a drug target in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jun 3. pii: AAC.00629.
    PubMed     Text format     Abstract available


  38. KOHLHOFF S, Huerta N, Hammerschlag MR
    In Vitro Activity of Levonadifloxacin (WCK 771) against Chlamydia pneumoniae.
    Antimicrob Agents Chemother. 2019 Jun 3. pii: AAC.01048.
    PubMed     Text format     Abstract available


  39. GARCIA MT, Valenzuela MV, Ferrandiz MJ, de la Campa AG, et al
    Reactive Oxygen Species Production is a Major Factor Directing the Post-antibiotic Effect of Fluoroquinolones in Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2019 Jun 3. pii: AAC.00737.
    PubMed     Text format     Abstract available


  40. O'DONNELL MR, Larsen MH, Brown TS, Jain P, et al
    Erratum for O'Donnell et al., "Early Detection of Emergent Extensively Drug-Resistant Tuberculosis by Flow Cytometry-Based Phenotyping and Whole-Genome Sequencing".
    Antimicrob Agents Chemother. 2019;63.
    PubMed     Text format    


  41. MACDONALD D, Thomson DD, Johns A, Valenzuela AC, et al
    Correction for Macdonald et al., "Inducible Cell Fusion Permits Use of Competitive Fitness Profiling in the Human Pathogenic Fungus Aspergillus fumigatus".
    Antimicrob Agents Chemother. 2019;63.
    PubMed     Text format    


    May 2019
  42. YU X, Gao X, Li C, Luo J, et al
    In Vitro Activity of bedaquiline and delamanid against Non-tuberculous Mycobacteria isolated in Beijing, China.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00031.
    PubMed     Text format     Abstract available


  43. CHOUDHARY DK, Bhakt P, Kaur R
    An essential role for the PI(3,5)P2 synthesis complex in caspofungin tolerance and virulence in Candida glabrata.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00886.
    PubMed     Text format     Abstract available


  44. ORTINES RV, Wang Y, Liu H, Dikeman DA, et al
    Efficacy of a multimechanistic monoclonal antibody combination against Staphylococcus aureus surgical site infections in mice.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00346.
    PubMed     Text format     Abstract available


  45. ARUANNO M, Glampedakis E, Lamoth F
    Echinocandins for the treatment of invasive aspergillosis: from laboratory to bedside.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00399.
    PubMed     Text format     Abstract available


  46. SUVICHAPANICH S, Wattanapokayakit S, Mushiroda T, Yanai H, et al
    Genome-Wide Association Study Confirming the Association of NAT2 with Susceptibility to Anti-tuberculosis Drug-Induced Liver Injury in Thai Patients.
    Antimicrob Agents Chemother. 2019 May 20. pii: AAC.02692.
    PubMed     Text format     Abstract available


  47. SEIFERT M, Capparelli E, Catanzaro DG, Rodwell TC, et al
    Using Mycobacterium tuberculosis single nucleotide polymorphisms to predict fluoroquinolone treatment response.
    Antimicrob Agents Chemother. 2019 May 13. pii: AAC.00076.
    PubMed     Text format     Abstract available


  48. ARUANNO M, Bachmann D, Sanglard D, Lamoth F, et al
    Link between heat shock protein 90 (Hsp90) and the mitochondrial respiratory chain in the caspofungin stress response of Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.00208.
    PubMed     Text format     Abstract available


  49. SANGUINETTI M, Canton E, Torelli R, Tumietto F, et al
    In Vitro Activity of Fenticonazole against Candida and Bacterial Vaginitis Isolates Determined by Mono- or Dual-Species Testing Assays.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.02693.
    PubMed     Text format     Abstract available


  50. PEREZ-CANTERO A, Lopez-Fernandez L, Guarro J, Capilla J, et al
    New insights into the Cyp51 contribution to azole resistance in Aspergillus section Nigri.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.00543.
    PubMed     Text format     Abstract available


  51. MURI L, Perny M, Zemp J, Grandgirard D, et al
    Combining Ceftriaxone with Doxycycline and Daptomycin Reduces Mortality, Neuroinflammation, Brain Damage and Hearing Loss in Infant Rat Pneumococcal Meningitis.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.00220.
    PubMed     Text format     Abstract available


  52. ZHANG Y, Zhu H, Fu L, Wang B, et al
    Identifying regimens containing a new drug candidate TBI-166 against Mycobacterium tuberculosis in vitro and in vivo.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.02496.
    PubMed     Text format     Abstract available


  53. AL-SHAER MH, Alghamdi WA, Alsultan A, An G, et al
    Fluoroquinolones in drug-resistant tuberculosis: culture conversion and pharmacokinetic/pharmacodynamic target attainment to guide dose selection.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.00279.
    PubMed     Text format     Abstract available


    April 2019
  54. LEPAK AJ, Zhao M, Marchillo K, VanHecker J, et al
    In vivo Pharmacodynamics of Omadacycline against Staphylococcus aureus in the Neutropenic Murine Thigh Infection Model.
    Antimicrob Agents Chemother. 2019 Apr 29. pii: AAC.00624.
    PubMed     Text format     Abstract available


  55. VARGAS-CRUZ N, Reitzel RA, Rosenblatt J, Chaftari AM, et al
    Nitroglycerin-Citrate-Ethanol (NiCE) Catheter Lock Solution is Highly Effective for in vitro Eradication of Candida auris Biofilm.
    Antimicrob Agents Chemother. 2019 Apr 29. pii: AAC.00299.
    PubMed     Text format     Abstract available


  56. KASPAR JR, Godwin MJ, Velsko IM, Richards VP, et al
    Spontaneously Arising Streptococcus mutans Variants With Reduced Susceptibility to Chlorhexidine Display Genetic Defects and Diminished Fitness.
    Antimicrob Agents Chemother. 2019 Apr 29. pii: AAC.00161.
    PubMed     Text format     Abstract available


  57. DIAZ IGLESIAS Y, Wilms T, Vanbever R, Van Bambeke F, et al
    Activity of antibiotics against Staphylococcus aureus in an in vitro model of biofilms in the context of cystic fibrosis: influence of the culture medium.
    Antimicrob Agents Chemother. 2019 Apr 29. pii: AAC.00602.
    PubMed     Text format     Abstract available


  58. VAN DEN ELSEN SHJ, Sturkenboom MGG, Akkerman OW, Manika K, et al
    Limited sampling strategies using linear regression and the Bayesian approach for therapeutic drug monitoring of moxifloxacin in tuberculosis patients.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00384.
    PubMed     Text format     Abstract available


  59. GHODOUSI A, Tagliani E, Karunaratne E, Niemann S, et al
    Isoniazid resistance in Mycobacterium tuberculosis is a heterogeneous phenotype comprised of overlapping MIC distributions with different underlying resistance mechanisms.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00092.
    PubMed     Text format     Abstract available


  60. IACOBINO A, Giannoni F, Pardini M, Piccaro G, et al
    The combination rifampin-nitazoxanide, but not rifampin-isoniazid-pyrazinamide-ethambutol, kills dormant Mycobacterium tuberculosis in hypoxia at neutral pH.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00273.
    PubMed     Text format     Abstract available


  61. LUN S, Tasneen R, Chaira T, Stec J, et al
    Advancing the therapeutic potential of indoleamides for tuberculosis.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00343.
    PubMed     Text format     Abstract available


  62. ERSOY SC, Abdelhady W, Li L, Chambers HF, et al
    Bicarbonate Resensitization of Methicillin-Resistant Staphylococcus aureus to beta-Lactam Antibiotics.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00496.
    PubMed     Text format     Abstract available


  63. KIM D, Lee H, Yoon EJ, Hong JS, et al
    Clinical prognoses of patients with a bloodstream infection caused by ampicillin-susceptible but penicillin-resistant Enterococcus faecalis: prospective observational study.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00291.
    PubMed     Text format     Abstract available


  64. ADDETIA A, Greninger AL, Adler A, Yuan S, et al
    A novel, widespread qacA allele results in reduced chlorhexidine susceptibility in Staphylococcus epidermidis.
    Antimicrob Agents Chemother. 2019 Apr 15. pii: AAC.02607.
    PubMed     Text format     Abstract available


  65. LEE A, Prideaux B, Lee MH, Zimmerman M, et al
    Tissue distribution and penetration of isavuconazole at the site of infection in Experimental Invasive Aspergillosis in Mice with underlying Chronic Granulomatous Disease.
    Antimicrob Agents Chemother. 2019 Apr 15. pii: AAC.00524.
    PubMed     Text format     Abstract available


  66. LOISEAU C, Brites D, Moser I, Coll F, et al
    Revised interpretation of the Hain Lifescience GenoType MTBC to differentiate Mycobacterium canettii and members of the M. tuberculosis complex.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.00159.
    PubMed     Text format     Abstract available


  67. KEBRIAEI R, Rice SA, Stamper KC, Seepersaud R, et al
    Daptomycin Dose-Ranging Evaluation with Single vs. Multi-Dose Ceftriaxone Combinations against Streptococcus mitis-oralis in an Ex Vivo Simulated Endocarditis Vegetation Model.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.00386.
    PubMed     Text format     Abstract available


  68. BERUBE BJ, Russell D, Castro L, Choi SR, et al
    Novel MenA inhibitors are bactericidal against Mycobacterium tuberculosis and synergize with electron-transport chain inhibitors.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.02661.
    PubMed     Text format     Abstract available


  69. RANJAN R, Srivastava A, Bharti R, Roy T, et al
    Preclinical development of inhalable D-cycloserine and ethionamide to overcome pharmacokinetic interaction and enhance efficacy against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.00099.
    PubMed     Text format     Abstract available


  70. SIOPI M, Mouton J, Pournaras S, Meletiadis J, et al
    In vitro and in vivo exposure-effect relationship of liposomal amphotericin B against Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.02673.
    PubMed     Text format     Abstract available


  71. HUANG Y, Alumasa JN, Callaghan LT, Baugh RS, et al
    A Small-Molecule Inhibitor of trans-Translation Synergistically Interacts with Cathelicidin Antimicrobial Peptides To Impair Survival of Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019;63.
    PubMed     Text format     Abstract available


  72. TETZ G, Collins M, Vikina D, Tetz V, et al
    In Vitro Activity of a Novel Antifungal Compound, MYC-053, against Clinically Significant Antifungal-Resistant Strains of Candida glabrata, Candida auris, Cryptococcus neoformans, and Pneumocystis spp.
    Antimicrob Agents Chemother. 2019;63.
    PubMed     Text format     Abstract available


  73. LI Y, Liu G, Zhai Z, Liu L, et al
    Erratum for Li et al., "Antibacterial Properties of Magnesium In Vitro and in an In Vivo Model of Implant-Associated Methicillin-Resistant Staphylococcus aureus Infection".
    Antimicrob Agents Chemother. 2019;63.
    PubMed     Text format    


  74. ARASTEHFAR A, Daneshnia F, Zomorodian K, Najafzadeh MJ, et al
    Low level of antifungal resistance in Iranian isolates of Candida glabrata recovered from blood samples from multicenter (2015-2018): Potential prognostic values of genotyping and sequencing of PDR1.
    Antimicrob Agents Chemother. 2019 Apr 1. pii: AAC.02503.
    PubMed     Text format     Abstract available


  75. OH JT, Cassino C, Schuch R
    Postantibiotic and Sub-MIC Effects of Exebacase (Lysin CF-301) Enhance Antimicrobial Activity Against Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Apr 1. pii: AAC.02616.
    PubMed     Text format     Abstract available


  76. AIGNER M, Wanner M, Kreidl P, Lass-Florl C, et al
    Candida in the respiratory tract potentially triggers galactomannan-positivity in non-haematological patients.
    Antimicrob Agents Chemother. 2019 Apr 1. pii: AAC.00138.
    PubMed     Text format     Abstract available


  77. SAINI V, Ammerman NC, Chang YS, Tasneen R, et al
    Treatment-shortening effect of a novel regimen combining high-dose rifapentine and clofazimine in pathologically distinct mouse models of tuberculosis.
    Antimicrob Agents Chemother. 2019 Apr 1. pii: AAC.00388.
    PubMed     Text format     Abstract available


    March 2019
  78. NISHIMOTO AT, Wiederhold NP, Flowers SA, Zhang Q, et al
    In vitro activities of the novel investigational tetrazoles VT-1161 and VT-1598 compared to the triazole antifungals against azole-resistant strains and clinical isolates of Candida albicans.
    Antimicrob Agents Chemother. 2019 Mar 25. pii: AAC.00341.
    PubMed     Text format     Abstract available


  79. PECK M, Rothenberg ME, Deng R, Lewin-Koh N, et al
    A phase 1, randomized, single ascending-dose study to investigate the safety, tolerability, and pharmacokinetics of DSTA4637S, an anti-Staphylococcus aureus THIOMAB antibody-antibiotic conjugate, in healthy volunteers.
    Antimicrob Agents Chemother. 2019 Mar 25. pii: AAC.02588.
    PubMed     Text format     Abstract available


  80. SEKAGGYA-WILTSHIRE C, Chirehwa M, Musaazi J, von Braun A, et al
    Low anti-tuberculosis drug concentrations in HIV-Tuberculosis co-infected adults with low body weight; is it time to update dosing guidelines?
    Antimicrob Agents Chemother. 2019 Mar 25. pii: AAC.02174.
    PubMed     Text format     Abstract available


  81. SEYEDMOUSAVI S, Chang Y, Law D, Birch M, et al
    Efficacy of olorofim (F901318) against Aspergillus fumigatus, A. nidulans, and A. tanneri in murine models of profound neutropenia and chronic granulomatous disease.
    Antimicrob Agents Chemother. 2019 Mar 18. pii: AAC.00129.
    PubMed     Text format     Abstract available


  82. SINGH KV, Murray BE
    Loss of a Major Enterococcal Polysaccharide Antigen (Epa) by Enterococcus faecalis is Associated with Increased Resistance to Ceftriaxone and Carbapenems.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.00481.
    PubMed     Text format     Abstract available


  83. SHI W, Cui P, Niu H, Zhang S, et al
    Introducing RpsA Point Mutations Delta438A and D123A into the Chromosome of M. tuberculosis Confirms their Role in Causing Resistance to Pyrazinamide.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.02681.
    PubMed     Text format     Abstract available


  84. ALGHAMDI WA, Alsultan A, Al-Shaer MH, An G, et al
    Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.00055.
    PubMed     Text format     Abstract available


  85. BUTTS A, Reitler P, Nishimoto AT, DeJarnette C, et al
    A systematic screen reveals a diverse collection of medications induce antifungal resistance in Candida species.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.00054.
    PubMed     Text format     Abstract available


  86. GERIAK M, Haddad F, Rizvi K, Rose W, et al
    Clinical Data on Daptomycin Plus Ceftaroline Versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.02483.
    PubMed     Text format     Abstract available


  87. JANARDHANAN J, Bouley R, Martinez-Caballero S, Peng Z, et al
    The quinazolinone allosteric inhibitor of PBP2a synergizes with piperacillin and tazobactam against methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.02637.
    PubMed     Text format     Abstract available


  88. XU J, Li SY, Almeida DV, Tasneen R, et al
    Contribution of pretomanid to novel regimens containing bedaquiline with either linezolid or moxifloxacin and pyrazinamide in murine models of tuberculosis.
    Antimicrob Agents Chemother. 2019 Mar 4. pii: AAC.00021.
    PubMed     Text format     Abstract available


  89. NISHIMOTO AT, Zhang Q, Hazlett B, Morschhauser J, et al
    The contribution of clinically-derived mutations in the gene encoding the zinc cluster transcription factor Mrr2 to fluconazole antifungal resistance and CDR1 expression in Candida albicans.
    Antimicrob Agents Chemother. 2019 Mar 4. pii: AAC.00078.
    PubMed     Text format     Abstract available


    February 2019
  90. NAKANO S, Fujisawa T, Ito Y, Chang B, et al
    Whole-genome sequencing analysis of multidrug-resistant serotype 15A Streptococcus pneumoniae in Japan and the emergence of a highly resistant serotype 15A-ST9084 clone.
    Antimicrob Agents Chemother. 2019 Feb 25. pii: AAC.02579.
    PubMed     Text format     Abstract available


  91. SARATHY J, Blanc L, Alvarez-Cabrera N, O'Brien P, et al
    Fluoroquinolone efficacy against tuberculosis is driven by penetration into lesions and activity against resident bacterial populations.
    Antimicrob Agents Chemother. 2019 Feb 25. pii: AAC.02516.
    PubMed     Text format     Abstract available


  92. BAINES SL, Jensen SO, Firth N, Goncalves da Silva A, et al
    Remodelling of pSK1 Family Plasmids and Enhanced Chlorhexidine Tolerance in a Dominant Hospital Lineage of Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02356.
    PubMed     Text format     Abstract available


  93. WARRILOW AG, Nishimoto AT, Parker JE, Price CL, et al
    The Evolution of Azole Resistance in Candida albicans Sterol 14alpha-Demethylase (CYP51) through Incremental Amino Acid Substitutions.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02586.
    PubMed     Text format     Abstract available


  94. GINGRAS H, Patron K, Bhattacharya A, Leprohon P, et al
    Gain and loss of function screens coupled to next generation sequencing for antibiotic mode of action and resistance studies in Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02381.
    PubMed     Text format     Abstract available


  95. DENEGA I, d'Enfert C, Bachellier-Bassi S
    Candida albicans biofilms are generally devoid of persister cells.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.01979.
    PubMed     Text format     Abstract available


  96. XU J, Wang B, Fu L, Zhu H, et al
    In vitro and in vivo activities of the riminophenazine TBI-166 against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02155.
    PubMed     Text format     Abstract available


  97. LIESE J, Schule L, Oberhettinger P, Tschorner L, et al
    Expansion of Vancomycin-resistant Enterococcus faecium in an academic tertiary hospital in Southwest Germany: a large-scale whole genome-based outbreak investigation.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.01978.
    PubMed     Text format     Abstract available


  98. VERREAULT D, Ennis J, Whaley K, Killeen SZ, et al
    Effective Treatment of Staphylococcal Enterotoxin B (SEB) Aerosol Intoxication in Rhesus Macaques using two parentally-administered High Affinity Monoclonal Antibodies.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02049.
    PubMed     Text format     Abstract available


  99. ROBERTSON GT, Ektnitphong VA, Scherman MS, McNeil MB, et al
    Efficacy and improved resistance potential of a cofactor-independent InhA inhibitor of Mycobacterium tuberculosis in a C3HeB/FeJ mouse model.
    Antimicrob Agents Chemother. 2019 Feb 11. pii: AAC.02071.
    PubMed     Text format     Abstract available


  100. KAUSHIK A, Ammerman NC, Tyagi S, Saini V, et al
    Activity of a long-acting injectable bedaquiline formulation in a paucibacillary mouse model of latent tuberculosis infection.
    Antimicrob Agents Chemother. 2019 Feb 11. pii: AAC.00007.
    PubMed     Text format     Abstract available


  101. GYGLI SM, Keller PM, Ballif M, Blochliger N, et al
    Whole genome sequencing for drug resistance profile prediction in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.02175.
    PubMed     Text format     Abstract available


  102. ZHANG H, Liu S, Yue J, Sun S, et al
    In vitro antimicrobial activity of diacerein on 76 gram-positive cocci isolates from bacterial keratitis patients and an in vivo study of diacerein eye drops on Staphylococcus aureus keratitis in mice.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.01874.
    PubMed     Text format     Abstract available


  103. PEE CJE, Pader V, Ledger EVK, Edwards AM, et al
    A FASII inhibitor prevents staphylococcal evasion of daptomycin by inhibiting phospholipid decoy production.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.02105.
    PubMed     Text format     Abstract available


  104. HONG SI, Lee YM, Park KH, Ryu BH, et al
    Clinical and Molecular Characteristics of qacA/B-Positive Methicillin-resistant Staphylococcus aureus Causing Bloodstream Infections.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.02157.
    PubMed     Text format     Abstract available


  105. PURI S, Kumar R, Rojas IG, Salvatori O, et al
    Iron Chelator Deferasirox Reduces Candida albicans Invasion of Oral Epithelial Cells and Infection Levels in Murine Oropharyngeal Candidiasis.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.02152.
    PubMed     Text format     Abstract available


  106. RYBAK JM, Doorley LA, Nishimoto AT, Barker KS, et al
    Abrogation of triazole resistance upon deletion of CDR1 in a clinical isolate of Candida auris.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.00057.
    PubMed     Text format     Abstract available


  107. KINNEAR CL, Patel TS, Young CL, Marshall V, et al
    Impact of an antimicrobial stewardship intervention on within and between patient daptomycin resistance evolution in vancomycin-resistant Enterococcus faecium.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.01800.
    PubMed     Text format     Abstract available


  108. SAVAGE KA, Parquet MDC, Allan DS, Davidson RJ, et al
    Erratum for Savage et al., "Iron Restriction to Clinical Isolates of Candida albicans by the Novel Chelator DIBI Inhibits Growth and Increases Sensitivity to Azoles In Vitro and In Vivo in a Murine Model of Experimental Vaginitis".
    Antimicrob Agents Chemother. 2019;63.
    PubMed     Text format    


    January 2019
  109. MENG L, Zhao H, Zhao S, Sun X, et al
    Inhibition of yeast-to-hypha transition and virulence of Candida albicans by 2-alkylaminoquinoline derivatives.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01891.
    PubMed     Text format     Abstract available


  110. KEBRIAEI R, Rice SA, Stamper KC, Rybak MJ, et al
    Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of Staphylococcus aureus in a PK/PD Model.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01743.
    PubMed     Text format     Abstract available


  111. SINGH KV, Arias CA, Murray BE
    Efficacy of Tedizolid Against Enterococci and Staphylococci, including cfr+ strains, in a Mouse Peritonitis Model.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02627.
    PubMed     Text format     Abstract available


  112. INDIANI C, Sauve K, Raz A, Abdelhady W, et al
    The Anti-Staphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood to Potentiate MRSA Bacteriolysis.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02291.
    PubMed     Text format     Abstract available


  113. ZHAO M, Lepak AJ, Marchillo K, Vanhecker J, et al
    APX001 Pharmacokinetic/Pharmacodynamic Target Determination against Aspergillus fumigatus in an in vivo Model of Invasive Pulmonary Aspergillosis.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02372.
    PubMed     Text format     Abstract available


  114. O'DONNELL MR, Larsen MH, Brown TS, Jain P, et al
    Early detection of emergent extensively drug resistant tuberculosis (XDR-TB) by flow cytometry-based phenotyping and whole genome sequencing.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01834.
    PubMed     Text format     Abstract available


  115. GARCIA-PRATS AJ, Purchase SE, Osman M, Draper HR, et al
    Pharmacokinetics, safety, and dosing of novel pediatric levofloxacin dispersible tablets in children with multidrug-resistant tuberculosis exposure.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01865.
    PubMed     Text format     Abstract available


  116. BAE JY, Jun KI, Kang CK, Song KH, et al
    The Efficacy of Intranasal Administration of the Recombinant Endolysin, SAL200, in a Lethal Murine Staphylococcus aureus Pneumonia Model.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02009.
    PubMed     Text format     Abstract available


  117. RUIZ P, Causse M, Vaquero M, Casal M, et al
    In vitro activity of Tedizolid against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01939.
    PubMed     Text format     Abstract available


  118. MARSHALL AC, Kidd SE, Lamont-Friedrich SJ, Arentz G, et al
    Aspergillus fumigatus thioredoxin reductase: structure, mechanism, and inhibition.
    Antimicrob Agents Chemother. 2019 Jan 14. pii: AAC.02281.
    PubMed     Text format     Abstract available


  119. JIANG JH, Dexter C, Cameron DR, Monk IR, et al
    Evolution of daptomycin resistance in coagulase negative staphylococci involves mutations of the essential two component regulator WalKR.
    Antimicrob Agents Chemother. 2019 Jan 7. pii: AAC.01926.
    PubMed     Text format     Abstract available


  120. DILWORTH TJ, Casapao AM, Ibrahim OM, Jacobs DM, et al
    Adjuvant beta-lactam therapy combined with vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: Does beta-lactam class matter?
    Antimicrob Agents Chemother. 2019 Jan 7. pii: AAC.02211.
    PubMed     Text format     Abstract available


  121. WASSERMAN S, Denti P, Brust JCM, Tareq M, et al
    Linezolid pharmacokinetics in South African patients with drug resistant tuberculosis and a high prevalence of HIV co-infection.
    Antimicrob Agents Chemother. 2019 Jan 7. pii: AAC.02164.
    PubMed     Text format     Abstract available


  122. GHAJAVAND H, Kargarpour Kamakoli M, Khanipour S, Pourazar Dizaji S, et al
    High Prevalence of Bedaquiline Resistance in Treatment-naive Tuberculosis Patients and Verapamil Effectiveness.
    Antimicrob Agents Chemother. 2019 Jan 2. pii: AAC.02530.
    PubMed     Text format     Abstract available


  123. CHOULES MP, Wolf NM, Lee H, Anderson JR, et al
    Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus.
    Antimicrob Agents Chemother. 2019 Jan 2. pii: AAC.02204.
    PubMed     Text format     Abstract available


  124. KHALIL ZG, Hill TA, De Leon Rodriguez LM, Lohman RJ, et al
    Structure-activity relationships of wollamide cyclic hexapeptides with activity against drug-resistant and intracellular Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jan 2. pii: AAC.01773.
    PubMed     Text format     Abstract available


    December 2018
  125. BORDALLO-CARDONA MA, Sanchez-Carrillo C, Bouza E, Munoz P, et al
    Detection of echinocandin-resistant Candida glabrata in blood cultures spiked with different percentages of FKS2 mutants.
    Antimicrob Agents Chemother. 2018 Dec 17. pii: AAC.02004.
    PubMed     Text format     Abstract available


  126. MENETREY A, Janin A, Pullman J, Overcash JS, et al
    Bone and Joint Tissues Penetration of the Staphylococcus-Selective Antibiotic Afabicin in Patients Undergoing Elective Hip Replacement Surgery.
    Antimicrob Agents Chemother. 2018 Dec 17. pii: AAC.01669.
    PubMed     Text format     Abstract available


  127. HEIDARI A, Quinlan M, Benjamin DJ, Laurence B, et al
    Isavuconazole in the Treatment of Coccidioidal Meningitis.
    Antimicrob Agents Chemother. 2018 Dec 17. pii: AAC.02232.
    PubMed     Text format     Abstract available


  128. WIEDERHOLD NP, Lockhart SR, Najvar LK, Berkow EL, et al
    The Fungal Cyp51 Specific Inhibitor VT-1598 Demonstrates In vitro and In vivo Activity against Candida auris.
    Antimicrob Agents Chemother. 2018 Dec 10. pii: AAC.02233.
    PubMed     Text format     Abstract available


  129. ANDREONI F, Toyofuku M, Menzi C, Kalawong R, et al
    Antibiotics stimulate vesicles formation in Staphylococcus aureus in a phage-dependent and independent fashion and via different routes.
    Antimicrob Agents Chemother. 2018 Dec 3. pii: AAC.01439.
    PubMed     Text format     Abstract available


  130. KOHLHOFF SA, Huerta N, Hammerschlag MR
    In vitro activity of Omadacycline against Chlamydia pneumoniae.
    Antimicrob Agents Chemother. 2018 Dec 3. pii: AAC.01907.
    PubMed     Text format     Abstract available


  131. MATSUO M, Hiramatsu M, Singh M, Sasaki T, et al
    Genetic and transcriptomic analyses of ciprofloxacin-tolerant Staphylococcus aureus isolated by the Replica Plating Tolerance Isolation System (REPTIS).
    Antimicrob Agents Chemother. 2018 Dec 3. pii: AAC.02019.
    PubMed     Text format     Abstract available


  132. STOTT KE, Beardsley J, Kolamunnage-Dona R, Castelazo AS, et al
    Correction for Stott et al., "Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis".
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


  133. STOTT KE, Beardsley J, Whalley S, Mukasa Kibengo F, et al
    Correction for Stott et al., "Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis".
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


    November 2018
  134. BARBER AE, Weber M, Kaerger K, Linde J, et al
    Comparative genomics of serial Candida glabrata isolates and the rapid acquisition of echinocandin resistance during therapy.
    Antimicrob Agents Chemother. 2018 Nov 26. pii: AAC.01628.
    PubMed     Text format     Abstract available


  135. AHMAD S, Joseph L, Parker JE, Asadzadeh M, et al
    ERG6 and ERG2 are major targets conferring reduced susceptibility to amphotericin B in clinical Candida glabrata isolates in Kuwait.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01900.
    PubMed     Text format     Abstract available


  136. WURSTER S, Lewis RE, Albert ND, Kontoyiannis DP, et al
    Pre-Exposure to Isavuconazole Increases the Virulence of Mucorales but not Aspergillus fumigatus in a Drosophila melanogaster Infection Model.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01896.
    PubMed     Text format     Abstract available


  137. SCHMIDT S, Schubert R, Tramsen L, Lehrnbecher T, et al
    Impact of Antifungal Compounds on Viability and Anti-Aspergillus Activity of Human Natural Killer Cells.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01993.
    PubMed     Text format     Abstract available


  138. GEBREMARIAM T, Alkhazraji S, Alqarihi A, Jeon HH, et al
    APX001 is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01713.
    PubMed     Text format     Abstract available


  139. DEKKERS BGJ, Akkerman OW, Alffenaar JWC
    The role of therapeutic drug monitoring in treatment optimization in tuberculosis and diabetes mellitus co-morbidity.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.02074.
    PubMed     Text format     Abstract available


  140. VAN RIJN SP, Zuur MA, Anthony R, Wilffert B, et al
    Evaluation of carbapenems for multi/extensive-drug resistant Mycobacterium tuberculosis treatment.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01489.
    PubMed     Text format     Abstract available


  141. MATSUO M, Yamamoto N, Hishinuma T, Hiramatsu K, et al
    Identification of a novel gene associated with high-level beta-lactam resistance in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3 and methicillin-resistant S. aureus strain N315.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.00712.
    PubMed     Text format     Abstract available


  142. ZIMMERLI W, Sendi P
    The Role of Rifampin against Staphylococcal Biofilm Infections in Vitro, in Animal Models, and in Orthopedic Device-Related Infections.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01746.
    PubMed     Text format     Abstract available


  143. ANDRES S, Groschel MI, Hillemann D, Merker M, et al
    A diagnostic algorithm to investigate pyrazinamide and ethambutol resistance in rifampicin resistant Mycobacterium tuberculosis isolates in a low incidence setting.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01798.
    PubMed     Text format     Abstract available


  144. PERSYN A, Rogiers O, Brock M, Vande Velde G, et al
    Monitoring of fluconazole and caspofungin activity against in vivo Candida glabrata biofilms by bioluminescence imaging.
    Antimicrob Agents Chemother. 2018 Nov 12. pii: AAC.01555.
    PubMed     Text format     Abstract available


  145. CHOJNACKI M, Philbrick A, Wucher B, Reed JN, et al
    Development of a broad-spectrum antimicrobial combination for the treatment of Staphylococcus aureus and Pseudomonas aeruginosa corneal infections.
    Antimicrob Agents Chemother. 2018 Nov 12. pii: AAC.01929.
    PubMed     Text format     Abstract available


  146. GREGOIRE M, Gaborit B, Deschanvres C, Lecomte R, et al
    High-dosage cefazolin achieves sufficient cerebrospinal diffusion to treat an external ventricular drainage-related Staphylococcus aureus ventriculitis.
    Antimicrob Agents Chemother. 2018 Nov 12. pii: AAC.01844.
    PubMed     Text format     Abstract available


  147. MEIKLE V, Mossberg AK, Mitra A, Hakansson AP, et al
    A protein complex from human milk enhances the activity of antibiotics and drugs against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Nov 12. pii: AAC.01846.
    PubMed     Text format     Abstract available


  148. MACDONALD D, Thomson DD, Johns A, Contreras Valenzuela A, et al
    Inducible cell fusion permits use of competitive fitness profiling in the human pathogenic fungus Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01615.
    PubMed     Text format     Abstract available


  149. BORDALLO-CARDONA MA, Agnelli C, Gomez-Nunez A, Sanchez-Carrillo C, et al
    MSH2 gene point mutations are not antifungal resistance markers in Candida glabrata.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01876.
    PubMed     Text format     Abstract available


  150. CHOI MJ, Won EJ, Joo MY, Park YJ, et al
    Emergence of Voriconazole-resistant Aspergillus flavus Isolates in Korean Hospitals: Microsatellite Typing and Resistance Mechanism Analysis.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01610.
    PubMed     Text format     Abstract available


  151. DE MIRANDA SILVA C, Hajihosseini A, Myrick J, Nole J, et al
    Effect of Moxifloxacin plus Pretomanid against Mycobacterium tuberculosis in Log-phase, Acid-phase and Non-Replicating-Persister (NRP)-phase in an in vitro Assay.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01695.
    PubMed     Text format     Abstract available


  152. BARROS EM, Martin MJ, Selleck EM, Lebreton F, et al
    Daptomycin resistance and tolerance due to loss-of-function in Staphylococcus aureus dsp1 and asp23.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01542.
    PubMed     Text format     Abstract available


  153. HOU X, Lee A, Jimenez-Ortigosa C, Kordalewska M, et al
    Rapid Detection of ERG11-Associated Azole Resistance and FKS-Associated Echinocandin Resistance in Candida auris.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01811.
    PubMed     Text format     Abstract available


  154. PICCINELLI G, Fernandes P, Bonfanti C, Caccuri F, et al
    Erratum for Piccinelli et al., "In Vitro Activity of Solithromycin against Erythromycin-Resistant Streptococcus agalactiae".
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


  155. GOMEZ-SANZ E, Schwendener S, Thomann A, Gobeli Brawand S, et al
    Correction for Gomez-Sanz et al., "First Staphylococcal Cassette Chromosome mec Containing a mecB-Carrying Gene Complex Independent of Transposon Tn6045 in a Macrococcus caseolyticus Isolate from a Canine Infection".
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


  156. VILCHEZE C, Jacobs WR Jr
    Reply to Yew et al., "Vitamin C and Mycobacterium tuberculosis Persisters".
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


  157. YEW WW, Chang KC, Leung CC, Chan DP, et al
    Vitamin C and Mycobacterium tuberculosis Persisters.
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


    October 2018
  158. RAFFAI T, Burian K, Janovak L, Bogdanov A, et al
    Vaginal gel component hydroxyethyl cellulose significantly enhances the infectivity of Chlamydia trachomatis serovars D and E.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.02034.
    PubMed     Text format     Abstract available


  159. VAN DEN ELSEN SHJ, Sturkenboom MGG, van 't Boveneind-Vrubleuskaya N, Skrahina A, et al
    Population pharmacokinetic model and limited sampling strategies for personalized dosing of levofloxacin in tuberculosis patients.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.01092.
    PubMed     Text format     Abstract available


  160. SHIELDS RK, Kline EG, Healey KR, Kordalewska M, et al
    Spontaneous mutational frequency and FKS mutation rates vary by echinocandin agent against Candida glabrata.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.01692.
    PubMed     Text format     Abstract available


  161. ANDES DR, Ghannoum MA, Mukherjee PK, Kovanda LL, et al
    Outcomes by Minimum Inhibitory Concentrations for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.01634.
    PubMed     Text format     Abstract available


  162. CAVALHEIRO M, Costa C, Silva-Dias A, Miranda IM, et al
    Unveiling the mechanisms of in vitro evolution towards fluconazole resistance of a Candida glabrata clinical isolate: a transcriptomics approach.
    Antimicrob Agents Chemother. 2018 Oct 22. pii: AAC.00995.
    PubMed     Text format     Abstract available


  163. TANABE K, Bonus M, Tomiyama S, Miyoshi K, et al
    FK506 resistance of Saccharomyces cerevisiae Pdr5 and Candida albicans Cdr1 involves mutations in the transmembrane domains and extracellular loops.
    Antimicrob Agents Chemother. 2018 Oct 22. pii: AAC.01146.
    PubMed     Text format     Abstract available


  164. LUNA-TAPIA A, Butts A, Palmer GE
    Loss of C-5 sterol desaturase activity in Candida albicans - azole resistance or merely trailing growth?
    Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01337.
    PubMed     Text format     Abstract available


  165. MELIEF E, Bonnett SA, Zuniga ES, Parish T, et al
    Activation of 2,4-diaminoquinazoline in Mycobacterium tuberculosis by Rv3161c, a putative dioxygenase.
    Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01505.
    PubMed     Text format     Abstract available


  166. RYBNIKER J, Andreas Kohl T, Barilar I, Niemann S, et al
    No evidence for acquired mutations associated with cytochrome bc 1-inhibitor resistance in 13,559 clinical Mycobacterium tuberculosis complex isolates.
    Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01317.
    PubMed     Text format     Abstract available


  167. ESPINEL-INGROFF A, Turnidge J, Alastruey-Izquierdo A, Botterel F, et al
    Method-dependent epidemiological cutoff values (ECVs) for detection of triazole resistance in Candida and Aspergillus species for the SYO colorimetric broth and Etest agar diffusion methods.
    Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01651.
    PubMed     Text format     Abstract available


  168. GLAMPEDAKIS E, Coste AT, Aruanno M, Bachmann D, et al
    Efficacy of antifungal monotherapies and combinations against Aspergillus calidoustus.
    Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01137.
    PubMed     Text format     Abstract available


  169. ROUARD C, Garnier F, Leraut J, Lepainteur M, et al
    Emergence and within-host genetic evolution of methicillin-resistant Staphylococcus aureus resistant to linezolid in a cystic fibrosis patient.
    Antimicrob Agents Chemother. 2018 Oct 1. pii: AAC.00720.
    PubMed     Text format     Abstract available


    September 2018
  170. DOAN TN, Cao P, Emeto TI, McCaw JM, et al
    Predicting the Outcomes of New Short-Course Regimens for Multi-Drug Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modelling.
    Antimicrob Agents Chemother. 2018 Sep 24. pii: AAC.01487.
    PubMed     Text format     Abstract available


  171. LOUIE A, Duncanson B, Myrick J, Maynard M, et al
    The Activity of Moxifloxacin against Acid-Phase and Non-Replicative Persister Phenotype Phase Mycobacterium tuberculosis in a Hollow Fiber Infection Model.
    Antimicrob Agents Chemother. 2018 Sep 24. pii: AAC.01470.
    PubMed     Text format     Abstract available


  172. SAMPAIO ADG, Gontijo AVL, Araujo HM, Koga-Ito CY, et al
    In vivo efficacy of ellagic acid against Candida albicans in a Drosophila melanogaster infection model.
    Antimicrob Agents Chemother. 2018 Sep 24. pii: AAC.01716.
    PubMed     Text format     Abstract available


  173. PADILLA E, Oms L, Espejo E, Gomez L, et al
    Rifampin resistance in staphylococci after rifaximin intake for surgical prophylaxis in elective colorectal surgery.
    Antimicrob Agents Chemother. 2018 Sep 24. pii: AAC.01353.
    PubMed     Text format     Abstract available


  174. RAMIREZ-ZAVALA B, Manz H, Englert F, Rogers PD, et al
    A hyperactive form of the zinc cluster transcription factor Stb5 causes YOR1 overexpression and beauvericin resistance in Candida albicans.
    Antimicrob Agents Chemother. 2018 Sep 24. pii: AAC.01655.
    PubMed     Text format     Abstract available


  175. TAN D, Htun HL, Koh J, Kanagasabai K, et al
    Comparative epidemiology of vancomycin-resistant enterococci colonization in an acute care hospital and its affiliated intermediate- and long-term care facilities in Singapore.
    Antimicrob Agents Chemother. 2018 Sep 17. pii: AAC.01507.
    PubMed     Text format     Abstract available


  176. DIAN S, Yunivita V, Ganiem AR, Pramaesya T, et al
    A double-blinded randomised placebo-controlled phase II trial to evaluate high dose rifampicin for tuberculous meningitis: a dose finding study.
    Antimicrob Agents Chemother. 2018 Sep 17. pii: AAC.01014.
    PubMed     Text format     Abstract available


  177. AURITI C, Ronchetti MP, Bersani I, Gennari F, et al
    Intrahepatic Administration of Amphotericin B Liposomal (Ambisome(R)) for the Management of a Liver Abscess from Candida albicans in a preterm infant.
    Antimicrob Agents Chemother. 2018 Sep 17. pii: AAC.01239.
    PubMed     Text format     Abstract available


  178. GUEST JM, Singh PK, Revankar SG, Chandrasekar PH, et al
    Isavuconazole for treatment of experimental fungal endophthalmitis caused by Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Sep 10. pii: AAC.01537.
    PubMed     Text format     Abstract available


  179. LEPAK AJ, Zhao M, Andes DR
    Pharmacodynamic Evaluation of Rezafungin (CD101) Against Candida auris in the Neutropenic Mouse Invasive Candidiasis Model.
    Antimicrob Agents Chemother. 2018 Sep 4. pii: AAC.01572.
    PubMed     Text format     Abstract available


  180. DOMON H, Maekawa T, Yonezawa D, Nagai K, et al
    Mechanism of macrolide-induced inhibition of pneumolysin release involves impairment of autolysin release in macrolide-resistant Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2018 Sep 4. pii: AAC.00161.
    PubMed     Text format     Abstract available


    August 2018
  181. CARTER GP, Ussher JE, Goncalves Da Silva A, Baines SL, et al
    Genomic analysis of multi-resistant Staphylococcus capitis associated with neonatal sepsis.
    Antimicrob Agents Chemother. 2018 Aug 27. pii: AAC.00898.
    PubMed     Text format     Abstract available


  182. MILLER WR, Singh KV, Arias CA, Murray BE, et al
    Adjunctive Clavulanic Acid Abolishes the Cefazolin Inoculum Effect in an Experimental Rat Model of Methicillin-Sensitive Staphylococcus aureus Endocarditis.
    Antimicrob Agents Chemother. 2018 Aug 27. pii: AAC.01158.
    PubMed     Text format     Abstract available


  183. ROUARD C, Doucet-Populaire F, Guillet-Caruba C, Villet M, et al
    Deletion of one 23S rDNA (rrl) copy contributes to the development of resistance to linezolid in Staphylococcus warneri.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01139.
    PubMed     Text format     Abstract available


  184. KENIYA MV, Sabherwal M, Wilson RK, Woods MA, et al
    Crystal structures of full-length lanosterol 14alpha-demethylases of prominent fungal pathogens Candida albicans and Candida glabrata provide tools for antifungal discovery.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01134.
    PubMed     Text format     Abstract available


  185. UKAI Y, Kuroiwa M, Kurihara N, Naruse H, et al
    Contributions of yap1 mutation and subsequent atrF upregulation to voriconazole resistance in Aspergillus flavus.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01216.
    PubMed     Text format     Abstract available


  186. KENIYA MV, Ruma YN, Tyndall JDA, Monk BC, et al
    Heterologous expression of full-length lanosterol 14alpha-demethylases of prominent fungal pathogens Candida albicans and Candida glabrata provides tools for antifungal discovery.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01131.
    PubMed     Text format     Abstract available


  187. CAO R, Teskey G, Islamoglu H, Abrahem R, et al
    Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01132.
    PubMed     Text format     Abstract available


  188. PAUL RA, Rudramurthy SM, Dhaliwal M, Singh P, et al
    Voriconazole resistance in clinical and environmental isolates of Aspergillus flavus - frequency and investigation into the role of multidrug efflux pumps.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01022.
    PubMed     Text format     Abstract available


  189. ALFARISI O, Mave V, Gaikwad S, Sahasrabudhe T, et al
    The effect of diabetes mellitus on the pharmacokinetics and pharmacodynamics of tuberculosis treatment.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01383.
    PubMed     Text format     Abstract available


  190. LUPIEN A, Vocat A, Foo CS, Blattes E, et al
    An optimized background regimen for treatment of active tuberculosis with the next-generation benzothiazinone Macozinone (PBTZ169).
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.00840.
    PubMed     Text format     Abstract available


  191. WIEDERHOLD NP, Xu X, Wang A, Najvar LK, et al
    In Vivo Efficacy of VT-1129 against Experimental Cryptococcal Meningitis with the Use of a Loading Dose-Maintenance Dose Administration Strategy.
    Antimicrob Agents Chemother. 2018 Aug 13. pii: AAC.01315.
    PubMed     Text format     Abstract available


  192. WALL G, Chaturvedi AK, Wormley FL Jr, Wiederhold NP, et al
    Screening a Repurposing Library for Inhibitors of Multi-Drug Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development.
    Antimicrob Agents Chemother. 2018 Aug 13. pii: AAC.01084.
    PubMed     Text format     Abstract available


  193. HO K, Huo W, Pas S, Dao R, et al
    Loss of function mutations in epaR confer resistance to phage NPV1 infection in Enterococcus faecalis OG1RF.
    Antimicrob Agents Chemother. 2018 Aug 13. pii: AAC.00758.
    PubMed     Text format     Abstract available


  194. KANDLER JL, Mercante AD, Dalton TL, Ezewudo MN, et al
    Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.00974.
    PubMed     Text format     Abstract available


  195. ISLA G, Leonardelli F, Tiraboschi IN, Refojo N, et al
    First clinical isolation of an azole-resistant Aspergillus fumigatus harboring a TR46/Y121F/T289A mutation in South America.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.00872.
    PubMed     Text format     Abstract available


  196. HEALEY KR, Kordalewska M, Jimenez Ortigosa C, Singh A, et al
    Limited ERG11 mutations identified in isolates of Candida auris directly contribute to reduced azole susceptibility.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.01427.
    PubMed     Text format     Abstract available


  197. KOSER CU, Heyckendorf J, Andres S, Olaru ID, et al
    Reply to Dookie et al., "Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis".
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


  198. DOOKIE N, Naidoo K, Padayatchi N
    Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis.
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


    July 2018
  199. JAGIELSKI T, Bakula Z, Brzostek A, Minias A, et al
    Characterization of mutations conferring resistance to rifampicin in Mycobacterium tuberculosis clinical strains.
    Antimicrob Agents Chemother. 2018 Jul 30. pii: AAC.01093.
    PubMed     Text format     Abstract available


  200. WEIKUM J, Ritzmann N, Jelden N, Klockner A, et al
    Sulfide protects Staphylococcus aureus from aminoglycoside antibiotics but cannot be regarded as a general defense mechanism against antibiotics.
    Antimicrob Agents Chemother. 2018 Jul 30. pii: AAC.00602.
    PubMed     Text format     Abstract available


  201. KIM NH, Park WB, Cho JE, Choi YJ, et al
    Effects of phage endolysin SAL200 combined with antibiotics on Staphylococcus aureus infection.
    Antimicrob Agents Chemother. 2018 Jul 23. pii: AAC.00731.
    PubMed     Text format     Abstract available


  202. RAZ A, Serrano A, Thaker M, Alston T, et al
    Lysostaphin lysibody leads to effective opsonization and killing of methicillin resistant Staphylococcus aureus in a murine model.
    Antimicrob Agents Chemother. 2018 Jul 23. pii: AAC.01056.
    PubMed     Text format     Abstract available


  203. WHALEY SG, Zhang Q, Caudle KE, Rogers PD, et al
    Relative Contribution of the ABC Transporters Cdr1, Pdh1, and Snq2 to Azole Resistance in Candida glabrata.
    Antimicrob Agents Chemother. 2018 Jul 23. pii: AAC.01070.
    PubMed     Text format     Abstract available


  204. PELOQUIN CA, Phillips PPJ, Mitnick CD, Eisenach K, et al
    Increased Doses Lead to Higher Drug Exposures of Levofloxacin for the Treatment of Tuberculosis.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00770.
    PubMed     Text format     Abstract available


  205. ZHAO Y, Lee MH, Paderu P, Lee A, et al
    Significantly improved pharmacokinetics enhances in vivo efficacy of APX001 against echinocandin and multidrug resistant Candida isolates in a mouse model of invasive candidiasis.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00425.
    PubMed     Text format     Abstract available


  206. YAN Q, Karau MJ, Raval YS, Patel R, et al
    Evaluation of Oritavancin in Combination with Rifampin, Gentamicin or Linezolid Against Prosthetic Joint Infection-Associated Methicillin-Resistant Staphylococcus aureus Biofilms by Time-Kill Assays.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00943.
    PubMed     Text format     Abstract available


  207. KANWAR A, Cadnum JL, Jencson AL, Donskey CJ, et al
    Impact of Antibiotic Treatment on the Burden of Nasal Staphylococcus aureus Among Hospitalized Patients.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00609.
    PubMed     Text format     Abstract available


  208. KIDD JM, Abdelraouf K, Asempa TE, Humphries RM, et al
    Pharmacodynamics of Daptomycin Against Enterococcus faecium and Enterococcus faecalis in the Murine Thigh Infection Model.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00506.
    PubMed     Text format     Abstract available


  209. PITON J, Vocat A, Lupien A, Foo C, et al
    Structure-based drug design and characterization of sulfonyl-piperazine benzothiazinone inhibitors of DprE1 from Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00681.
    PubMed     Text format     Abstract available


  210. PIETERMAN ED, Te Brake LHM, de Knegt GJ, van der Meijden A, et al
    Assessment of the additional value of verapamil to a moxifloxacin and linezolid combination regimen in a murine tuberculosis model.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.01354.
    PubMed     Text format     Abstract available


  211. WIEDERHOLD NP, Najvar LK, Garvey EP, Brand SR, et al
    The Fungal Cyp-51 Inhibitor VT-1129 is Efficacious in an Experimental Model of Cryptococcal Meningitis.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.01071.
    PubMed     Text format     Abstract available


  212. HOYER AR, Johnson CJ, Hoyer MR, Kernien JF, et al
    Echinocandin treatment of Candida albicans biofilms enhances neutrophil extracellular trap (NET) formation.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.00797.
    PubMed     Text format     Abstract available


  213. AGUILAR-PEREZ C, Gracia B, Rodrigues L, Vitoria A, et al
    Synergy between circular bacteriocin AS-48 and ethambutol against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.00359.
    PubMed     Text format     Abstract available


  214. DANION F, Jullien V, Rouzaud C, Abdel Fattah M, et al
    Is it time for systematic voriconazole pharmacogenomic investigation for central nervous system aspergillosis?
    Antimicrob Agents Chemother. 2018 Jul 2. pii: AAC.00705.
    PubMed     Text format     Abstract available


  215. PARDOS DE LA GANDARA M, Borges V, Chung M, Milheirico C, et al
    Correction for Pardos de la Gandara et al., "Genetic Determinants of High-Level Oxacillin Resistance in Methicillin-Resistant Staphylococcus aureus".
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


    June 2018
  216. TAJ-ALDEEN SJ, Salah H, Perez WB, Almaslamani M, et al
    Molecular analysis of resistance and detection of non-wild type strains using ECV values of Etest for amphotericin B and echinocandins for bloodstream Candida infections from a tertiary hospital in Qatar.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00214.
    PubMed     Text format     Abstract available


  217. CAMPEAU SA, Schuetz AN, Kohner P, Arias CA, et al
    Variability of daptomycin minimum inhibitory concentrations for Enterococcus faecium when measured by reference broth microdilution and gradient diffusion tests.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00745.
    PubMed     Text format     Abstract available


  218. LEE H, Yoon EJ, Kim D, Kim JW, et al
    Ceftaroline resistance by clone-specific polymorphism in penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00485.
    PubMed     Text format     Abstract available


  219. RANCOITA PMV, Cugnata F, Gibertoni Cruz AL, Borroni E, et al
    Validating a 14-drug microtitre plate containing bedaquiline and delamanid for large-scale research susceptibility testing of Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00344.
    PubMed     Text format     Abstract available


  220. HORITA Y, Alsultan A, Kwara A, Antwi S, et al
    Evaluation of the Adequacy of WHO revised Dosages of the First-Line Anti-Tuberculosis Drugs in Children with Tuberculosis using Population Pharmacokinetic Modeling and Simulations.
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00008.
    PubMed     Text format     Abstract available


  221. UMEYAMA T, Hayashi Y, Shimosaka H, Inukai T, et al
    Cas9/CRISPR genome editing to demonstrate the contribution of Cyp51A Gly138Ser to azole resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00894.
    PubMed     Text format     Abstract available


  222. STOTT KE, Beardsley J, Kolamunnage-Dona R, Santoyo Castelazo A, et al
    Population pharmacokinetics and cerebrospinal fluid penetration of fluconazole in adults with cryptococcal meningitis.
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00885.
    PubMed     Text format     Abstract available


  223. TRUONG-BOLDUC QC, Wang Y, Hooper DC
    Tet38 Efflux Pump Contributes to Fosfomycin Resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.00927.
    PubMed     Text format     Abstract available


  224. WANG SK, Gilchrist A, Loukitcheva A, Plotkin BJ, et al
    The Prevalence of a Cefazolin Inoculum Effect Associated with blaZ Gene Types Among Methicillin-Susceptible Staphylococcus aureus Isolates from Four Major Medical Centers in Chicago.
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.00382.
    PubMed     Text format     Abstract available


  225. DABAS Y, Xess I, Bakshi S, Mahapatra M, et al
    "Emergence of azole resistant Aspergillus fumigatus from immunocompromised hosts in India".
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.02264.
    PubMed     Text format     Abstract available


  226. DU PRE S, Beckmann N, Almeida MC, Sibley GEM, et al
    The effect of the novel antifungal drug F901318 (Olorofim) on the growth and viability of Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.00231.
    PubMed     Text format     Abstract available


  227. SIMITSOPOULOU M, Chlichlia K, Kyrpitzi D, Walsh TJ, et al
    Pharmacodynamic and immunomodulatory effects of micafungin on host responses against biofilms of Candida parapsilosis in comparison to those of Candida albicans.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00478.
    PubMed     Text format     Abstract available


  228. DE MIRANDA SILVA C, Hajihosseini A, Myrick J, Nole J, et al
    Effect of Linezolid plus Bedaquiline against Mycobacterium tuberculosis in Log-Phase, Acid-Phase and Non-Replicating-Persister (NRP)-Phase in an In vitro Assay.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00856.
    PubMed     Text format     Abstract available


  229. CEBALLOS S, Kim C, Ding D, Mobashery S, et al
    Activities of oxadiazole antibacterials against Staphylococcus aureus and other Gram-positive bacteria.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00453.
    PubMed     Text format     Abstract available


  230. DRUSANO GL, Myrick J, Maynard M, Nole J, et al
    Linezolid Kills Acid Phase and Non-replicative Persister Phase Mycobacterium tuberculosis in a Hollow Fiber Infection Model.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00221.
    PubMed     Text format     Abstract available


    May 2018
  231. SAVAGE KA, Parquet MDC, Allan DS, Davidson RJ, et al
    Iron restriction to clinical isolates of Candida albicans by the novel chelator DIBI inhibits growth and increases sensitivity to azoles in vitro and in vivo in a murine model of experimental vaginitis.
    Antimicrob Agents Chemother. 2018 May 29. pii: AAC.02576.
    PubMed     Text format     Abstract available


  232. ZONG Z, Jing W, Shi J, Wen S, et al
    Comparison of in vitro activity and MIC distributions between the novel oxazolidinone delpazolid and linezolid against multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in China.
    Antimicrob Agents Chemother. 2018 May 29. pii: AAC.00165.
    PubMed     Text format     Abstract available


  233. JAHANBAKHSH S, Singh NB, Yim J, Rose WE, et al
    Evaluation of Telavancin Alone and Combined with Ceftaroline or Rifampin against Methicillin-Resistant Staphylococcus aureus (MRSA) in an in vitro Biofilm Model.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.00567.
    PubMed     Text format     Abstract available


  234. SHOEN C, DeStefano M, Hafkin B, Cynamon M, et al
    In vitro and in vivo activity of contezolid (MRX-I) against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.00493.
    PubMed     Text format     Abstract available


  235. GOEMAERE B, Lagrou K, Spriet I, Hendrickx M, et al
    Clonal spread in Candida glabrata bloodstream isolates and fluconazole resistance affected by prolonged exposure: a 12-year single-center study in Belgium.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.00591.
    PubMed     Text format     Abstract available


  236. BROWN GANDT A, Griffith EC, Lister IM, Billings LL, et al
    In vivo and in vitro effects of a ClpP activating antibiotic against vancomycin resistant enterococci.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.00424.
    PubMed     Text format     Abstract available


  237. KEBRIAEI R, Rice SA, Singh KV, Stamper KC, et al
    Efficacy of Daptomycin Monotherapy and In Combination with beta-lactams for Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions: Influence of The Inoculum Effect.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00315.
    PubMed     Text format     Abstract available


  238. POELMANS J, Himmelreich U, Vanherp L, Zhai L, et al
    A multimodal imaging approach enables in vivo assessment of antifungal treatment in a mouse model of invasive pulmonary aspergillosis.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00240.
    PubMed     Text format     Abstract available


  239. LUO J, Yu X, Jiang G, Fu Y, et al
    In Vitro Activity of Clofazimine against Non-tuberculous Mycobacteriaisolated in Beijing, China.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00072.
    PubMed     Text format     Abstract available


  240. LOPEZ-SANCHEZ A, Perez-Cantero A, Torrado-Salmeron C, Martin-Vicente A, et al
    Experimental Amphotericin B-Deoxycholate formulations for pulmonary aspergillosis: efficacy, biodistribution and nephrotoxicity.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00489.
    PubMed     Text format     Abstract available


  241. STOTT KE, Beardsley J, Whalley S, Kibengo FM, et al
    Amphotericin B Deoxycholate in adults with Cryptococcal Meningitis; a Population Pharmacokinetic Model and Meta-Analysis of Outcomes.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.02526.
    PubMed     Text format     Abstract available


  242. BOUDJEMAA R, Cabriel C, Dubois-Brissonnet F, Bourg N, et al
    Failure of daptomycin to kill Staphylococcus aureus: impact of bacterial membrane fatty acid composition.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00023.
    PubMed     Text format     Abstract available


  243. GUO H, Zhou L, He Y, Gao C, et al
    Natamycin and Azithromycin are Synergistic in vitro against Ocular Pathogenic Aspergillus flavus species complex and Fusarium solani species complex Isolates.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00077.
    PubMed     Text format     Abstract available


  244. AMMERMAN NC, Swanson RV, Bautista EM, Almeida DV, et al
    Impact of Clofazimine Dosing on Treatment-Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00636.
    PubMed     Text format     Abstract available


  245. TIWARI KB, Gatto C, Walker S, Wilkinson BJ, et al
    Targocil-exposure of Staphylococcus aureus Blocks Translocation of the Major Autolysin Atl Across the Membrane Resulting in a Significant Decrease in Autolysis.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00323.
    PubMed     Text format     Abstract available


  246. KASPAR U, de Haro Sautto JA, Molinaro S, Peters G, et al
    The novel phage-derived antimicrobial agent HY-133 is active against livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA).
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00385.
    PubMed     Text format     Abstract available


  247. KAUFMANN SHE
    Indole Propionic Acid: a Small Molecule Links between Gut Microbiota and Tuberculosis.
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


    April 2018
  248. BUTTS A, Reitler P, Ge W, Fortwendel JR, et al
    Commonly used oncology drugs decrease antifungal effectiveness against Candida and Aspergillus species.
    Antimicrob Agents Chemother. 2018 Apr 30. pii: AAC.00504.
    PubMed     Text format     Abstract available


  249. BORDALLO-CARDONA MA, Marcos-Zambrano LJ, Sanchez-Carrillo C, Bouza E, et al
    Resistance to echinocandins in Candida can be detected by performing the Etest directly on blood culture samples.
    Antimicrob Agents Chemother. 2018 Apr 30. pii: AAC.00162.
    PubMed     Text format     Abstract available


  250. SIALA W, Rodriguez-Villalobos H, Fernandes P, Tulkens PM, et al
    Activity of combinations of antistaphylococcal antibiotics with fusidic acid against staphylococcal biofilms in in vitro static and dynamic models.
    Antimicrob Agents Chemother. 2018 Apr 30. pii: AAC.00598.
    PubMed     Text format     Abstract available


  251. SHI W, Chen J, Zhang S, Zhang W, et al
    Identification of novel mutations in LprG (rv1411c), rv0521,rv3630, rv0010c, ppsC,cyp128 associated with pyrazinoic acid/pyrazinamide resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Apr 23. pii: AAC.00430.
    PubMed     Text format     Abstract available


  252. BUTLER-LAPORTE G, Lee TC, Cheng MP
    Increasing Rates of Penicillin Sensitivity in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Apr 23. pii: AAC.00680.
    PubMed     Text format     Abstract available


  253. BOOT M, Commandeur S, Subudhi AK, Bahira M, et al
    Accelerating early anti-tuberculosis drug discovery by creating mycobacterial indicator strains that predict mode of action.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.00083.
    PubMed     Text format     Abstract available


  254. ZHENG H, Williams JT, Coulson GB, Haiderer ER, et al
    HC2091 kills Mycobacterium tuberculosis by targeting the MmpL3 mycolic acid transporter.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.02459.
    PubMed     Text format     Abstract available


  255. BEN-SHMUEL A, Glinert I, Sittner A, Bar-David E, et al
    Treating Anthrax-Induced Meningitis in Rabbits.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.00298.
    PubMed     Text format     Abstract available


  256. LIU Y, Pertinez H, Davies GR, Gillespie SH, et al
    Moxifloxacin replacement in contemporary tuberculosis drug regimens is ineffective against persistent Mycobacterium tuberculosis: Novel insights from the Cornell mouse model.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.00190.
    PubMed     Text format     Abstract available


  257. LYONS MA
    Modeling and Simulation of Pretomanid Pharmacokinetics in Pulmonary Tuberculosis Patients.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.02359.
    PubMed     Text format     Abstract available


  258. STEFAN MA, Ugur FS, Garcia GA
    SOURCE OF THE FITNESS DEFECT IN RIFAMYCIN-RESISTANT M. TUBERCULOSIS RNA POLYMERASE AND THE MECHANISM OF COMPENSATION BY MUTATIONS IN THE beta'-SUBUNIT.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.00164.
    PubMed     Text format     Abstract available


  259. KORDALEWSKA M, Lee A, Park S, Berrio I, et al
    Understanding echinocandin resistance in the emerging pathogen Candida auris.
    Antimicrob Agents Chemother. 2018 Apr 9. pii: AAC.00238.
    PubMed     Text format     Abstract available


  260. GARCIA-RUBIO R, Alcazar-Fuoli L, Monteiro MC, Monzon S, et al
    Aspergillus fumigatus cyp51A polymorphisms, an insight on their significance.
    Antimicrob Agents Chemother. 2018 Apr 9. pii: AAC.00241.
    PubMed     Text format     Abstract available


  261. LASKARIS P, Vicentefranqueira R, Helynck O, Jouvion G, et al
    A novel polyaminocarboxylate compound to treat murine pulmonary aspergillosis by interfering with zinc metabolism.
    Antimicrob Agents Chemother. 2018 Apr 9. pii: AAC.02510.
    PubMed     Text format     Abstract available


  262. GHANNOUM M, Long L, Larkin EL, Isham N, et al
    SCY-078, a Novel Oral Glucan Synthase Inhibitor, for the Treatment of Invasive Aspergillosis: Evaluation of Antifungal Activity Singly and in Combination.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.00244.
    PubMed     Text format     Abstract available


  263. LI JL, Yang N, Huang L, Chen D, et al
    Pyocyanin Inhibits Chlamydia Infection by Disabling Infectivity of the Elementary Body and Disrupting Intracellular Growth.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02260.
    PubMed     Text format     Abstract available


  264. BARMAN TK, Kumar M, Mathur T, Namba E, et al
    In vitro and in vivo activities of DS-2969b, a novel GyrB inhibitor, and its water-soluble prodrug, DS11960558, against methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02556.
    PubMed     Text format     Abstract available


  265. LAMONTAGNE BOULET M, Isabelle C, Guay I, Brouillette E, et al
    Tomatidine, a lead antibiotic molecule that targets Staphylococcus aureus ATP synthase subunit C.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02197.
    PubMed     Text format     Abstract available


  266. LI FJ, Palmer KL
    EfrEF and the transcription regulator ChlR are required for chlorhexidine stress response in Enterococcus faecalis V583.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.00267.
    PubMed     Text format     Abstract available


  267. SINGH A, Healey KR, Yadav P, Upadhyaya G, et al
    Absence of azole or echinocandin resistance in Candida glabrata isolates in India despite background prevalence of strains with defects in DNA mismatch repair pathway.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.00195.
    PubMed     Text format     Abstract available


  268. GSALLER F, Furukawa T, Carr PD, Rash B, et al
    The mechanistic basis of pH-dependent 5-flucytosine resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02593.
    PubMed     Text format     Abstract available


  269. BASSO V, Garcia A, Tran DQ, Schaal JB, et al
    Fungicidal potency and mechanisms of theta-defensins against multi-drug resistant Candida species.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.00111.
    PubMed     Text format     Abstract available


  270. GARCIA-DE-LA-MARIA C, Gasch O, Garcia-Gonzalez J, Soy D, et al
    The Combination of Daptomycin plus Fosfomycin has Synergistic, Potent and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) in a Rabbit Model of Experimental Endocarditis (EE).
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02633.
    PubMed     Text format     Abstract available


  271. YANG F, Zhang L, Wakabayashi H, Myers J, et al
    Correction for Yang et al., "Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of FKS Genes and Cell Wall Remodeling".
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


  272. CHEN Y, Mallick J, Maqnas A, Sun Y, et al
    Erratum for Chen et al., "Chemogenomic Profiling of the Fungal Pathogen Candida albicans".
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


    March 2018
  273. CHEN CL, Cheng MH, Kuo CF, Cheng YL, et al
    Dextromethorphan Attenuates NADPH Oxidase-regulated GSK-3beta and NF-kappaB Activation and Reduces Nitric Oxide Production in Group A Streptococcal Infection.
    Antimicrob Agents Chemother. 2018 Mar 26. pii: AAC.02045.
    PubMed     Text format     Abstract available


  274. HIRAYAMA T, Miyazaki T, Yamagishi Y, Mikamo H, et al
    Clinical and Microbiological Characteristics of Candida guilliermondii and Candida fermentati.
    Antimicrob Agents Chemother. 2018 Mar 26. pii: AAC.02528.
    PubMed     Text format     Abstract available


  275. ESCHENAUER GA, Carver PL, Patel TS, Lin SW, et al
    Survival in Patients with Candida glabrata Bloodstream Infections is Associated with Fluconazole Dose.
    Antimicrob Agents Chemother. 2018 Mar 26. pii: AAC.02566.
    PubMed     Text format     Abstract available


  276. HOU X, Xiao M, Wang H, Yu SY, et al
    Profiling of PDR1 and MSH2 in Candida glabrata Bloodstream Isolates from a Multi-Center Study in China.
    Antimicrob Agents Chemother. 2018 Mar 26. pii: AAC.00153.
    PubMed     Text format     Abstract available


  277. BADER JC, Lakota EA, Flanagan S, Ong V, et al
    Overcoming the Resistance Hurdle: PK-PD Target Attainment Analyses of Rezafungin (CD101) for Candida albicans and Candida glabrata.
    Antimicrob Agents Chemother. 2018 Mar 19. pii: AAC.02614.
    PubMed     Text format     Abstract available


  278. LUTHER MK, Parente DM, Caffrey AR, Daffinee K, et al
    Clinical and genetic risk factors for biofilm-forming Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.02252.
    PubMed     Text format     Abstract available


  279. TOMAS ME, Mana TSC, Wilson BM, Nerandzic MM, et al
    Tapering Courses of Oral Vancomycin Induce Persistent Disruption of the Microbiota that Provide Colonization Resistance to Clostridium difficile and Vancomycin-Resistant Enterococci in Mice.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.02237.
    PubMed     Text format     Abstract available


  280. KOK EY, Vallejo JG, Sommer LM, Rosas L, et al
    Association of Vancomycin MIC and Molecular Characteristics With Clinical Outcomes in Methicillin-Susceptible Staphylococcus aureus Acute Hematogenous Osteoarticular Infections in Children.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.00084.
    PubMed     Text format     Abstract available


  281. SMITH JR, Yim J, Rice S, Stamper K, et al
    The combination of tedizolid and daptomycin against methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.00101.
    PubMed     Text format     Abstract available


  282. CHEN Y, Li Z, Han X, Tian S, et al
    Elevated MIC values to imidazole drugs among Aspergillus fumigatus isolates with TR34/L98H/S297T/F495I mutation.
    Antimicrob Agents Chemother. 2018 Mar 5. pii: AAC.01549.
    PubMed     Text format     Abstract available


  283. MERCER DK, Katvars LK, Hewitt F, Smith DW, et al
    Correction for Mercer et al., "NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus".
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


  284. ARIAS CA, Reyes J, Carvajal LP, Rincon S, et al
    Erratum for Arias et al., "A Prospective Cohort Multicenter Study of Molecular Epidemiology and Phylogenomics of Staphylococcus aureus Bacteremia in Nine Latin American Countries".
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


    February 2018
  285. GUIRAO-ABAD JP, Sanchez-Fresneda R, Machado F, Arguelles JC, et al
    MICAFUNGIN ENHANCES THE HUMAN MACROPHAGE RESPONSE TO Candida albicans THROUGH beta-GLUCAN EXPOSURE.
    Antimicrob Agents Chemother. 2018 Feb 26. pii: AAC.02161.
    PubMed     Text format     Abstract available


  286. LU Z, Jia X, Chen Y, Han X, et al
    Identification and Characterization of Key Charged Residues in the Cofilin Protein Involved in Azole Susceptibility, Apoptosis, and Virulence of Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Feb 26. pii: AAC.01659.
    PubMed     Text format     Abstract available


  287. GUPTA R, Felix CR, Akerman MP, Akerman KJ, et al
    Gold(III) macrocycles and chelates targeting Mycobacterium tuberculosis and Mycobacterium abscessus: evidence for inhibition of topoisomerase 1A.
    Antimicrob Agents Chemother. 2018 Feb 26. pii: AAC.01696.
    PubMed     Text format     Abstract available


  288. BERKOW EL, Nunnally NS, Bandea A, Kuykendall R, et al
    Detection of TR34/L98H Cyp51A mutation through passive surveillance for azole-resistant Aspergillus fumigatus in the US, 2015-2017.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02240.
    PubMed     Text format     Abstract available


  289. CHEN C, Gardete S, Jansen RS, Shetty A, et al
    Verapamil targets membrane energetics in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02107.
    PubMed     Text format     Abstract available


  290. HEMANTH KUMAR AK, Kumar A, Kannan T, Bhatia R, et al
    Pharmacokinetics of second-line anti-tuberculosis drugs in children with multidrug-resistant tuberculosis in India.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02410.
    PubMed     Text format     Abstract available


  291. MELETIADIS J, Siopi M, Tsakris A, Mouton JW, et al
    A new marker of echinocandins activity in an in vitro PK/PD model correlates with an animal model of Aspergillus fumigatus infection.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02322.
    PubMed     Text format     Abstract available


  292. WEINER M, Gelfond J, Johnson-Pais TL, Engle M, et al
    Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.-11187G>A Polymorphism in Adults with Pulmonary Tuberculosis.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.01802.
    PubMed     Text format     Abstract available


  293. ZUUR MA, Ghimire S, Bolhuis MS, Wessels AMA, et al
    The Pharmacokinetics of 2000 mg Ertapenem in Tuberculosis Patients.
    Antimicrob Agents Chemother. 2018 Feb 12. pii: AAC.02250.
    PubMed     Text format     Abstract available


  294. COLLEY T, Sehra G, Chowdhary A, Alanio A, et al
    In Vitro and In Vivo Efficacy of a Novel and Long Acting Fungicidal Azole, PC1244 on Aspergillus fumigatus Infection.
    Antimicrob Agents Chemother. 2018 Feb 12. pii: AAC.01941.
    PubMed     Text format     Abstract available


  295. MURATA M, Kosai K, Yamauchi S, Sasaki D, et al
    In vitro activity of lascufloxacin against Streptococcus pneumoniae with mutations in the quinolone resistance-determining regions (QRDRs).
    Antimicrob Agents Chemother. 2018 Feb 12. pii: AAC.01971.
    PubMed     Text format     Abstract available


  296. IMBERT S, Normand AC, Ranque S, Costa JM, et al
    Species identification and in vitro-antifungal susceptibility of Aspergillus terreus species complex clinical isolates: a French multicentre study.
    Antimicrob Agents Chemother. 2018 Feb 12. pii: AAC.02315.
    PubMed     Text format     Abstract available


  297. CHEN Y, Yuan Z, Shen X, Wu J, et al
    Time to Multidrug-Resistant Tuberculosis Treatment Initiation in Association with Treatment Outcomes in Shanghai, China.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.02259.
    PubMed     Text format     Abstract available


  298. SAO EMANI C, Williams MJ, Wiid I, Baker B, et al
    Compounds with potential activity against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.02236.
    PubMed     Text format     Abstract available


  299. ESPINEL-INGROFF A, Turnidge J, Alastruey-Izquierdo A, Dannaoui E, et al
    Posaconazole MIC distributions for Aspergillus fumigatus SC by four methods: Impact of Cyp51A mutations on estimation of epidemiological cutoff values (ECVs/ECOFFs).
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.01916.
    PubMed     Text format     Abstract available


  300. KHAN Z, Ahmad S, Mokaddas E, Meis JF, et al
    Development of echinocandin resistance in Candida tropicalis following short-term exposure to caspofungin for empiric therapy.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.01926.
    PubMed     Text format     Abstract available


  301. LYSKOVA P, Hubka V, Svobodova L, Barrs V, et al
    Antifungal susceptibility of the Aspergillus viridinutans complex: comparison of two in vitro methods.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.01927.
    PubMed     Text format     Abstract available


  302. ELJAALY K, Alshehri S, Erstad BL
    Safety of Anti-Staphylococcal Penicillins versus Cefazolin: A Systematic Review and Meta-Analysis.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.01816.
    PubMed     Text format     Abstract available


  303. RIAT A, Plojoux J, Gindro K, Schrenzel J, et al
    Azole resistance of Aspergillus fumigatus isolates from the environment and the clinic in Switzerland.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.02088.
    PubMed     Text format     Abstract available


    January 2018
  304. IDELEVICH EA, Kriegeskorte A, Schleimer N, Peters G, et al
    In Vitro Susceptibility of Clinical Staphylococcus aureus Small Colony Variants to beta-Lactam and Non-ss-Lactam Antibiotics.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02532.
    PubMed     Text format     Abstract available


  305. WANG Q, Pang Y, Jing W, Liu Y, et al
    Clofazimine for Treatment of Pulmonary Extensively Drug-Resistant Tuberculosis in China.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02149.
    PubMed     Text format     Abstract available


  306. HUO F, Luo J, Shi J, Zong Z, et al
    Increasing Prevalence of Rifampicin-Resistant Mycobacterium tuberculosis is Associated with the Transmission of Strains Harboring Compensatory Mutations in China: A 10-year Comparative Analysis.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02303.
    PubMed     Text format     Abstract available


  307. ZHAO M, Lepak AJ, VanScoy B, Bader JC, et al
    In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02542.
    PubMed     Text format     Abstract available


  308. ADANI S, Bhowmick T, Weinstein MP, Narayanan N, et al
    Clinical Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin at an Institution with Suppressed MIC Reporting: Impact of Vancomycin MIC.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02512.
    PubMed     Text format     Abstract available


  309. PEYRUSSON F, Tulkens PM, Van Bambeke F
    Cellular pharmacokinetics and intracellular activity of gepotidacin against Staphylococcus aureus with different resistance phenotypes in models of cultured phagocytic cells.
    Antimicrob Agents Chemother. 2018 Jan 22. pii: AAC.02245.
    PubMed     Text format     Abstract available


  310. SUWUNNAKORN S, Wakabayashi H, Kordalewska M, Perlin DS, et al
    FKS2 and FKS3 genes of opportunistic human pathogen Candida albicans influence echinocandin susceptibility.
    Antimicrob Agents Chemother. 2018 Jan 22. pii: AAC.02299.
    PubMed     Text format     Abstract available


  311. CHACKO K, Sullivan M, Beckford C, Altman D, et al
    The genetic basis of emerging vancomycin, linezolid, and daptomycin heteroresistance in a case of persistent Enterococcus faecium bacteremia.
    Antimicrob Agents Chemother. 2018 Jan 16. pii: AAC.02007.
    PubMed     Text format     Abstract available


  312. ORTINES RV, Liu H, Cheng LI, Cohen TS, et al
    Neutralizing alpha-toxin accelerates healing of Staphylococcus aureus-infected wounds in normal and diabetic mice.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.02288.
    PubMed     Text format     Abstract available


  313. SHARMA C, Kumar R, Kumar N, Masih A, et al
    Investigation of multiple resistance mechanisms in voriconazole resistant Aspergillus flavus clinical isolates from a chest hospital surveillance in Delhi, India.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01928.
    PubMed     Text format     Abstract available


  314. GARNAUD C, Garcia-Oliver E, Wang Y, Maubon D, et al
    The Rim pathway mediates antifungal tolerance in Candida albicans through newly identified Rim101 transcriptional targets including Hsp90 and Ipt1.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01785.
    PubMed     Text format     Abstract available


  315. LONG N, Zeng L, Qiao S, Li L, et al
    Aspergillus fumigatus Afssn3-Afssn8 Pair Reverse regulates Azole Resistance by Conferring Extracellular Polysaccharide, Sphingolipid Pathway Intermediates and Efflux Pumps to Biofilm.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01978.
    PubMed     Text format     Abstract available


  316. YU SJ, Chang YL, Chen YL
    Deletion of ADA2 increases antifungal drug susceptibility and virulence in Candida glabrata.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01924.
    PubMed     Text format     Abstract available


  317. DIJKSTRA JA, van der Laan T, Akkerman OW, Bolhuis MS, et al
    In vitro drug susceptibility of Mycobacterium tuberculosis for amikacin, kanamycin and capreomycin.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01724.
    PubMed     Text format     Abstract available


  318. YU X, Zeng X, Shi W, Hu Y, et al
    The validation of Cycloserine efficacy in treatment of multidrug-resistant and extensively drug-resistant tuberculosis in Beijing, China.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01824.
    PubMed     Text format     Abstract available


  319. TOP J, Sinnige JC, Brouwer EC, Werner G, et al
    Identification of a novel genomic island associated with vanD-type vancomycin-resistance in six Dutch vancomycin-resistant Enterococcus faecium.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01793.
    PubMed     Text format     Abstract available


  320. HAGER CL, Larkin EL, Long L, Abidi FZ, et al
    In vitro and in vivo Evaluation of the Antifungal Activity of APX001A/APX001 Against Candida auris.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.02319.
    PubMed     Text format     Abstract available


  321. BORDALLO-CARDONA MA, Marcos-Zambrano LJ, Sanchez-Carrillo C, de la Pedrosa EGG, et al
    Mutant prevention concentration and mutant selection window of micafungin and anidulafungin in clinical Candida glabrata isolates.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01982.
    PubMed     Text format     Abstract available


  322. BHATTACHARYA S, Fries BC
    Enhanced Efflux Pump Activity in Old Candida glabrata.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.02227.
    PubMed     Text format     Abstract available


  323. VILCHEZE C, Kim J, Jacobs WR Jr
    Vitamin C potentiates the killing of Mycobacterium tuberculosis by the first-line tuberculosis drugs isoniazid and rifampicin in mice.
    Antimicrob Agents Chemother. 2018 Jan 3. pii: AAC.02165.
    PubMed     Text format     Abstract available


  324. ALSULTAN A, Furin JJ, Du Bois J, van Brakel E, et al
    Erratum for Alsultan et al., "Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis".
    Antimicrob Agents Chemother. 2017;62.
    PubMed     Text format    


    December 2017
  325. SADER HS, Mendes RE, Duncan LR, Pfaller MA, et al
    Antimicrobial Activity of Dalbavancin Tested against Staphylococcus aureus with Decreased Susceptibility to Glycopeptides, Daptomycin, and/or Linezolid from United States Medical Centers.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.02397.
    PubMed     Text format     Abstract available


  326. DOMPREH A, Tang X, Zhou J, Yang H, et al
    Effect of genetic variation of NAT2 on isoniazid, SLCO1B1, and CES2 on rifampin pharmacokinetics in Ghanaian children with tuberculosis.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.02099.
    PubMed     Text format     Abstract available


  327. ELDESOUKY HE, Mayhoub A, Hazbun TR, Seleem MN, et al
    Reversal of azole resistance in Candida albicans by sulfa antibacterial drugs.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.00701.
    PubMed     Text format     Abstract available


  328. IKEH MAC, Fidel PL Jr, Noverr MC
    Prostaglandin E2 Receptor Antagonist with Antimicrobial Activity Against Methicillin Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.01920.
    PubMed     Text format     Abstract available


  329. JUMAH MTB, Vasoo S, Menon SR, De PP, et al
    Pharmacokinetic/pharmacodynamic (PK/PD) Determinants of Vancomycin Efficacy in Enterococcal Bacteremia.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.01602.
    PubMed     Text format     Abstract available


  330. AUNG WW, Ei PW, Nyunt WW, Htwe MM, et al
    Pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Myanmar.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.01984.
    PubMed     Text format     Abstract available


  331. DHINGRA S, Buckey JC, Cramer RA
    Hyperbaric Oxygen Reduces Aspergillus fumigatus Proliferation In Vitro and Influences In Vivo Disease Outcomes.
    Antimicrob Agents Chemother. 2017 Dec 11. pii: AAC.01953.
    PubMed     Text format     Abstract available


  332. CARTER GP, Schultz MB, Baines SL, Goncalves da Silva A, et al
    Topical antibiotic use co-selects for the carriage of mobile genetic elements conferring resistance to unrelated antimicrobials in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Dec 11. pii: AAC.02000.
    PubMed     Text format     Abstract available


  333. SARATHY JP, Via LE, Weiner D, Blanc L, et al
    Extreme drug tolerance of Mycobacterium tuberculosis in caseum.
    Antimicrob Agents Chemother. 2017 Dec 4. pii: AAC.02266.
    PubMed     Text format     Abstract available


  334. CHEN Y, Mallick J, Maqnas A, Sun Y, et al
    Chemogenomic profiling of the fungal pathogen Candida albicans.
    Antimicrob Agents Chemother. 2017 Dec 4. pii: AAC.02365.
    PubMed     Text format     Abstract available


  335. HOGAN S, O'Gara JP, O'Neill E
    Novel treatment of Staphylococcus aureus device-related infections using fibrinolytic agents.
    Antimicrob Agents Chemother. 2017 Dec 4. pii: AAC.02008.
    PubMed     Text format     Abstract available


  336. LEE H, Ahn S, Hwang NY, Jeon K, et al
    Limited Effect of Later-generation Fluoroquinolones in the Treatment of Ofloxacin-resistant and Moxifloxacin-susceptible Multidrug-resistant Tuberculosis.
    Antimicrob Agents Chemother. 2017 Dec 4. pii: AAC.01784.
    PubMed     Text format     Abstract available


    November 2017
  337. DESHPANDE D, Srivastava S, Bendet P, Martin KR, et al
    On the antibacterial and sterilizing effect of benzylpenicillin in tuberculosis.
    Antimicrob Agents Chemother. 2017 Nov 27. pii: AAC.02232.
    PubMed     Text format     Abstract available


  338. CHANNABASAPPA S, Durgaiah M, Chikkamadaiah R, Kumar S, et al
    Efficacy of novel anti-staphylococcal ectolysin P128 in a rat model of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia.
    Antimicrob Agents Chemother. 2017 Nov 27. pii: AAC.01358.
    PubMed     Text format     Abstract available


  339. PATHIRANA RU, Friedman J, Norris HL, Salvatori O, et al
    Fluconazole Resistant Candida auris is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses.
    Antimicrob Agents Chemother. 2017 Nov 20. pii: AAC.01872.
    PubMed     Text format     Abstract available


  340. BASAS J, Palau M, Ratia C, Luis Del Pozo J, et al
    High-dose daptomycin is effective as an antibiotic-lock therapy in a rabbit model of Staphylococcus epidermidis catheter-related infection.
    Antimicrob Agents Chemother. 2017 Nov 20. pii: AAC.01777.
    PubMed     Text format     Abstract available


  341. ABBADI BL, Villela AD, Rodrigues-Junior VS, Subtil FT, et al
    Revisiting activation of and the mechanism of resistance to the compound IQG-607 in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Nov 20. pii: AAC.02222.
    PubMed     Text format     Abstract available


  342. ZHENG X, Berti AD, McCrone S, Roch M, et al
    Combination antibiotic exposure selectively alters the development of vancomycin intermediate resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Nov 20. pii: AAC.02100.
    PubMed     Text format     Abstract available


  343. TRUONG J, Veillette JJ, Forland SC
    Outcomes of vancomycin plus a beta-lactam versus vancomycin only for the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01554.
    PubMed     Text format     Abstract available


  344. DENTI P, Garcia-Prats AJ, Draper HR, Wiesner L, et al
    Levofloxacin population pharmacokinetics in South African children treated for multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01521.
    PubMed     Text format     Abstract available


  345. VAN DER LAAN LE, Garcia-Prats AJ, Schaaf HS, Tikiso T, et al
    Pharmacokinetics and drug-drug interactions of lopinavir/ritonavir administered with first and second-line antituberculosis drugs in HIV-infected children treated for multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.00420.
    PubMed     Text format     Abstract available


  346. EL-HOSSARY EM, Forstner KU, Francois P, Baud D, et al
    A Novel Mechanism of Inactivating Antibacterial Nitro Compounds in the Human Pathogen Staphylococcus aureus by Overexpression of a NADH-dependent Flavin Nitroreductase.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01510.
    PubMed     Text format     Abstract available


  347. HEYCKENDORF J, Andres S, Koser CU, Olaru ID, et al
    What is resistance? Impact of phenotypic versus molecular drug resistance testing on multi- and extensively drug-resistant tuberculosis therapy.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01550.
    PubMed     Text format     Abstract available


  348. CHANDRA J, Ghannoum MA
    CD101, a Novel Echinocandin Possesses Potent Anti-biofilm Activity Against Early and Mature Candida albicans Biofilms.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01750.
    PubMed     Text format     Abstract available


  349. BELLEY A, Arhin FA, Moeck G
    Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an in vitro Pharmacokinetic/Pharmacodynamic Model.
    Antimicrob Agents Chemother. 2017 Nov 6. pii: AAC.01873.
    PubMed     Text format     Abstract available


  350. GARDNER SG, Marshall DD, Daum RS, Powers R, et al
    Metabolic Mitigation of Staphylococcus aureus Vancomycin Intermediate-Level Susceptibility.
    Antimicrob Agents Chemother. 2017 Nov 6. pii: AAC.01608.
    PubMed     Text format     Abstract available


    October 2017
  351. SUN Q, Xiao TY, Liu HC, Zhao XQ, et al
    Mutations within embCAB are associated with variable level of ethambutol resistance in Mycobacterium tuberculosis isolates from China.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.01279.
    PubMed     Text format     Abstract available


  352. REFOS JM, Vonk AG, Ten Kate MT, Verbrugh HA, et al
    Chitinase induction prior to caspofungin treatment of experimental invasive aspergillosis in neutropenic rats does not enhance survival.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.00960.
    PubMed     Text format     Abstract available


  353. WILLBY MJ, Wijkander M, Havumaki J, Johnson K, et al
    Detection of Mycobacterium tuberculosis pncA mutations by the NIPRO GenoscholarPZA-TB II as compared to conventional sequencing.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.01871.
    PubMed     Text format     Abstract available


  354. ARGUDIN MA, Roisin S, Dodemont M, Nonhoff C, et al
    Mutations at the ribosomal S10 gene in clinical strains of Staphylococcus aureus with reduced susceptibility to tigecycline.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.01852.
    PubMed     Text format     Abstract available


  355. BERUBE BJ, Parish T
    Combinations of respiratory chain inhibitors have enhanced bactericidal activity against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01677.
    PubMed     Text format     Abstract available


  356. GENESTET C, Ader F, Pichat C, Lina G, et al
    Combined Antibacterial Effect of Isoniazid and Rifampicin on Four Mycobacterium tuberculosis Strains: in Vitro Experiments and Response-Surface Modeling.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01413.
    PubMed     Text format     Abstract available


  357. SAPUTO S, Faustoferri RC, Quivey RG Jr
    Vitamin D compounds are bactericidal against Streptococcus mutans and target the bacitracin-associated efflux system.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01675.
    PubMed     Text format     Abstract available


  358. HOLTAPPELS M, Swinnen E, De Groef L, Wuyts J, et al
    The antifungal activity of oleylphosphocholine (OlPC) on in vitro and in vivo Candida albicans biofilms.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01767.
    PubMed     Text format     Abstract available


  359. SAPUTO S, Faustoferri RC, Quivey RG Jr
    A drug repositioning approach reveals Streptococcus mutans is susceptible to a diverse range of established antimicrobials and non-antibiotics.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01674.
    PubMed     Text format     Abstract available


  360. ACCOCEBERRY I, Rougeron A, Biteau N, Chevrel P, et al
    A CTG clade Candida yeast genetically engineered for the genotype-phenotype characterization of azole antifungal resistance in human pathogenic yeasts.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01483.
    PubMed     Text format     Abstract available


  361. BHARDWAJ P, Hans A, Ruikar K, Guan Z, et al
    Reduced chlorhexidine and daptomycin susceptibility in vancomycin-resistant Enterococcus faecium after serial chlorhexidine exposure.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01235.
    PubMed     Text format     Abstract available


  362. JONES D, Elshaboury RH, Munson E, Dilworth TJ, et al
    A Retrospective Analysis of Treatment and Clinical Outcomes among Patients with Methicillin-susceptible Staphylococcus aureus Bloodstream Isolates Possessing Detectable mecA by a Commercial PCR Assay Compared to Patients with Methicillin-resistant Sta
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01396.
    PubMed     Text format     Abstract available


  363. XU J, Tasneen R, Peloquin CA, Almeida DV, et al
    Verapamil increases the bioavailability and efficacy of bedaquiline but not clofazimine in a murine model of tuberculosis.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01692.
    PubMed     Text format     Abstract available


  364. RAFFETIN A, Courbin V, Jullien V, Dannaoui E, et al
    In vitro combination of Isavuconazole with Echinocandins against Azole-Susceptible and -Resistant Aspergillus spp.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01382.
    PubMed     Text format     Abstract available


  365. DE WELZEN L, Eldholm V, Maharaj K, Manson AL, et al
    Whole transcriptome and genomic analysis of extensively drug-resistant Mycobacterium tuberculosis clinical isolates identifies downregulation of ethA as a mechanism of ethionamide resistance.
    Antimicrob Agents Chemother. 2017 Oct 9. pii: AAC.01461.
    PubMed     Text format     Abstract available


  366. MOUSAVI SF, Pana M, Feizabadi M, Jalali P, et al
    Diversity of mosaic pbp2x families of penicillin-resistant Streptococcus pneumoniae from Iran and Romania.
    Antimicrob Agents Chemother. 2017 Oct 2. pii: AAC.01535.
    PubMed     Text format     Abstract available


  367. NAKATANI Y, Opel-Reading HK, Merker M, Machado D, et al
    Role of alanine racemase mutations in Mycobacterium tuberculosis D-cycloserine resistance.
    Antimicrob Agents Chemother. 2017 Oct 2. pii: AAC.01575.
    PubMed     Text format     Abstract available


  368. HEALEY KR, Nagasaki Y, Zimmerman M, Kordalewska M, et al
    The gastrointestinal tract is a major source of echinocandin drug resistance in a murine model of Candida glabrata colonization and systemic dissemination.
    Antimicrob Agents Chemother. 2017 Oct 2. pii: AAC.01412.
    PubMed     Text format     Abstract available


    September 2017
  369. LIU BH, Lei CW, Zhang AY, Pan Y, et al
    Co-location of the multiresistance gene cfr and the fosfomycin resistance gene fosD on a novel plasmid in Staphylococcus arlettae from chicken farm.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01388.
    PubMed     Text format     Abstract available


  370. BUIL JB, van der Lee HAL, Rijs AJMM, Zoll J, et al
    AGAR-BASED SCREENING FOR AZOLE RESISTANCE IN ASPERGILLUS FUMIGATUS USING VIPcheck: A SINGLE CENTRE EVALUATION.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01250.
    PubMed     Text format     Abstract available


  371. DESAI AV, Kovanda LL, Hope WW, Andes D, et al
    Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01034.
    PubMed     Text format     Abstract available


  372. JIMENEZ-ORTIGOSA C, Moore C, Denning DW, Perlin DS, et al
    Emergence of Echinocandin Resistance due to a Point Mutation in the fks1 Gene of Aspergillus fumigatus in a Patient with Chronic Pulmonary Aspergillosis.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01277.
    PubMed     Text format     Abstract available


  373. XU W, DeJesus MA, Rucker N, Engelhart CA, et al
    Chemical genomic interaction profiling reveals determinants of intrinsic antibiotic resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01334.
    PubMed     Text format     Abstract available


  374. BERNAL-MARTINEZ L, Gil H, Rivero-Menendez O, Gago S, et al
    Development and validation of a High Resolution Melting Assay to detect azole resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01083.
    PubMed     Text format     Abstract available


  375. KIDWAI S, Park CY, Mawatwal S, Tiwari P, et al
    The dual mechanism of action of 5-Nitro-1,10-Phenanthroline against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.00969.
    PubMed     Text format     Abstract available


  376. PARK YN, Srikantha T, Daniels KJ, Jacob MR, et al
    A Protocol For Identifying Natural Agents That Selectively Affect Adhesion, Thickness, Architecture, Cellular Phenotypes, ECM and Human White Cell Impenetrability of Candida albicans Biofilms.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01319.
    PubMed     Text format     Abstract available


  377. KONG EF, Tsui C, Kucharikova S, Van Dijck P, et al
    Modulation of Staphylococcus aureus Response to Antimicrobials by the Candida albicans Quorum Sensing Molecule Farnesol.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01573.
    PubMed     Text format     Abstract available


  378. METCALFE JZ, Streicher E, Theron G, Colman RE, et al
    Mycobacterium tuberculosis subculture results in loss of potentially clinically relevant heteroresistance.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.00888.
    PubMed     Text format     Abstract available


  379. NEGRI CE, Goncalves SS, Sousa ACP, Bergamasco MD, et al
    Triazole resistance is still not emerging in A fumigatus isolates causing invasive aspergillosis in Brazilian patients.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.00608.
    PubMed     Text format     Abstract available


    August 2017
  380. VALENTINE-KING MA, Brown MB
    Antibacterial Resistance in Ureaplasma species and Mycoplasma hominis Isolates from Urine Cultures in College-aged Females.
    Antimicrob Agents Chemother. 2017 Aug 21. pii: AAC.01104.
    PubMed     Text format     Abstract available


    July 2017
  381. YAMADA K, Saito R, Muto S, Kashiwa M, et al
    Molecular characterization of fluoroquinolone-resistant Moraxella catarrhalis variants generated in vitro by stepwise selection.
    Antimicrob Agents Chemother. 2017 Jul 31. pii: AAC.01336.
    PubMed     Text format     Abstract available


  382. CHOI H, Kim SY, Kim DH, Huh HJ, et al
    Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-resistant Mycobacterium abscessus Lung Disease.
    Antimicrob Agents Chemother. 2017 Jul 24. pii: AAC.01146.
    PubMed     Text format     Abstract available


  383. CHHIBBER S, Shukla A, Kaur S
    Transfersomal phage cocktail: an effective treatment against methicillin resistant S.aureus (MRSA) mediated Skin and Soft tissue infections (SSTIs).
    Antimicrob Agents Chemother. 2017 Jul 24. pii: AAC.02146.
    PubMed     Text format     Abstract available


  384. GALLAGHER LA, Coughlan S, Black NS, Lalor P, et al
    Tandem amplification of SCCmec can drive high level methicillin resistance in MRSA.
    Antimicrob Agents Chemother. 2017 Jul 17. pii: AAC.00869.
    PubMed     Text format     Abstract available


  385. HEINE HS, Shadomy SV, Boyer AE, Chuvala L, et al
    Evaluation of Combination Drug Therapy for Treatment of Antibiotic Resistant Inhalation Anthrax in a Murine Model.
    Antimicrob Agents Chemother. 2017 Jul 10. pii: AAC.00788.
    PubMed     Text format     Abstract available


  386. HENNEBIQUE A, Bidart M, Jarraud S, Beraud L, et al
    Digital PCR for detection and quantification of fluoroquinolone resistance in Legionella pneumophila.
    Antimicrob Agents Chemother. 2017 Jul 3. pii: AAC.00628.
    PubMed     Text format     Abstract available


    June 2017
  387. MATSUMOTO S, Singley CM, Hoover J, Nakamura R, et al
    Efficacy of Cefiderocol against Carbapenem-resistant Gram-negative bacilli in Immunocompetent Rat Respiratory Tract Infection Models Recreating Human Plasma pharmacokinetics.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.00700.
    PubMed     Text format     Abstract available


  388. TODD DA, Parlet CP, Crosby HA, Malone CL, et al
    Targeting quorum sensing signal biosynthesis to fight antibiotic resistant infections: Ambuic acid as a model inhibitor.
    Antimicrob Agents Chemother. 2017 Jun 12. pii: AAC.00263.
    PubMed     Text format     Abstract available


    May 2017
  389. LODISE T, Ye MJ, Zhao Q
    Prevalence of Invasive Infections due to Carbapenem-Resistant Enterobacteriaceae Among Adult Patients Across US Hospitals.
    Antimicrob Agents Chemother. 2017 May 30. pii: AAC.00228.
    PubMed     Text format     Abstract available


  390. KUNKEL A, Lewnard JA, Pitzer VE, Cohen T, et al
    Antimicrobial Resistance Risks of Cholera Prophylaxis for United Nations Peacekeepers.
    Antimicrob Agents Chemother. 2017 May 22. pii: AAC.00026.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: